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CHAPTER I 
INTRODUCTION 
 
1.1 Natural Products Isolation 
       Marketed plants are very important items of trade in many parts of the world. The 
community uses these for a variety of purposes such as food, cosmetics, flavors, 
spices, and medicines. It seems that plants that are used for medicinal purposes form 
the most common category. 
       For at least five thousand years humankind has relied on natural products as the 
primary source for medicines. Herbs, bread mold, even leeches were employed to 
bring relief to the sick and infirm. There was little significant change over much of 
this time period; however, the last two centuries have brought an explosion of 
understanding of how these natural products are produced and how they interact with 
other organisms. The last two centuries have seen the isolation of the first commercial 
drug (morphine), the use of microbial products as medicines (penicillin), and even a 
use for the lowly leech (the anticoagulant, hirudin) (Newman et al., 2000). Who 
knows what the next two centuries will bring us. Now, at the start of a new 
millennium, it is estimated by the World Health Organization (Farnsworth et al., 
1985). that 80% of the world’s inhabitants must rely on traditional medicines for 
health care; these traditional medicines are primarily plant-based. Even in the 
remaining population, natural products are important in health care. It is estimated 
that 25% of all prescriptions dispensed in the USA contain a plant extract or active 
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ingredients derived from plants. It is also estimated that 74% of the 119 currently 
most important drugs contain active ingredients from plants used in traditional 
medicine. Another study of the most prescribed drugs in the USA indicated that a 
majority contained either a natural product, or a natural product was used in the 
synthesis or design of the drug. All of these estimations demonstrate the importance 
of natural products in drug discovery. 
       Until the 1970’s, drug discovery was essentially based on serendipity. Rational 
drug discovery only began with the advent of molecular biology and computers. With 
the cost of drug development approaching $350 million (USA) per drug (Cragg et al., 
1997), many discovery groups are debating “quantity” vs. “quality” strategies in an 
effort to reduce costs. The “quantity” approach is that of combinatorial chemistry, 
which can provide libraries of thousands of compounds in a short period of time. For 
example, this approach can provide thousands of analogs of the decapeptide 
gramicidin S1, Figure 1.1 (1), for testing, a task impossible for natural product 
isolation. However, these libraries tend to lack novelty and are usually based on 
natural product targets anyway. One “quality” approach is natural product screening 
and isolation, which provides fewer compounds over a longer period of time. 
Additionally, this strategy can lead to unforeseen novel molecular structures that 
combinatorial chemistry would be unlikely to reveal. The unique peroxy-bond of 
artemisinin (2), the ring system of paclitaxel (Taxol) (3), and the stereochemistry of 
erythromycin A (4) are synthetically challenging and are unlikely to have been 
discovered through a combinatorial approach. Many pharmaceutical companies are 
now pursuing both combinatorial and isolation strategies. Only time will tell which 
strategy will predominate, but to paraphrase a respected natural product chemist,  
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perhaps Nature is the world’s best combinatorial chemist. 
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Figure 1.1. Natural products. 
 
       Medicinal herbs are a significant source of synthetic and herbal drugs. In the 
commercial market, medicinal herbs are used as raw drugs, extracts, or tinctures. 
Isolated active constituents are used for applied research. For the last few decades, 
phytochemistry (study of plants) has been making rapid progress and herbal products 
are becoming popular. There has been dramatic rise in the sale of herbal products like 
Allium sativum, Hypericum perforatum, Spirulina, Echinacea angustifolia, Ginkgo 
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biloba, and Silybum marianum. 
       Owing to growing demand for herbals, the current need is to intensify research in 
the field of medicinal herbs and to get authentic information on the subject. Herbal 
products are often questioned for quality control and assurance. The majority of the 
herbal products fail in laboratory tests for the active constituents mentioned on the 
label. Extracts standardised to active constituents and marker compounds have 
definite advantage over the crude drugs (Pal Singh et al., 2002).  
       Clinacanthus nutans (Burm. f.) Lindau belongs to the family of Acanthaceae. 
This family includes many species, which are known to have medical properties. In 
Thailand, many Thai medicinal plants have been collected, including medicinal plants 
of the family Acanthaceae including: Andrographis paniculata (Burm. f.) Nees, 
Acanthus ebrateatus Vahl, Barleria lupulina Lidl, Clinacanthus nutans (Burm. f.) 
Lindau, Justicia betonica Linn, Rhinacanthus nasutus Linn, Ruellia tuberosa Linn, 
and Thunbergia laurifolia Linn (Hancharnlerd et al., 1994) (Table 1.1).  
 
Table 1.1. Medicinal Plants of the Family Acanthaceae in Thailand and Their 
Traditional Use. 
Plant Species Characteristic Seasonal Blooming Traditional Use 
1. Acanthusebra 
teatus  Vahl 
 
Shrub 
 
 
 
Rainy season 
 
 
 
All stem and seeds: 
healing of wounds, 
worm protection, fresh 
leaves for healthy hair
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Table 1.1. (Continued). 
Plant Species Characteristic Seasonal Blooming Traditional Use 
2. Andrographis 
paniculata 
(Burm. f.) Nees 
Perennial shrub All year Leaves and stems: 
healing sore throat 
and diarrhea 
3. Barleria 
lupulina Lindl. 
Shrub Rainy season Blended leaves: 
healing inflammation 
after insect bites 
4. Clinacanthus 
nutans (Burm. 
f.) Lindau 
Shrub In January Fresh leaves: healing 
burns and scalds 
5. Justicia 
betonica Linn 
Shrub All year No information 
6. Rhinacanthus 
nasutus Linn. 
Small Shrub In January Leaves and roots: 
healing skin diseases 
Roots are antiseptic 
7. Ruellia 
tuberosa Linn. 
Perennial shrub 
(long life) 
Rainy season Roots: healing 
urinary tract 
inflammation and 
reducing toxicity 
8. Thunbergia 
laurifolia Linn. 
Shrub Rainy season Leaves: healing 
stomach ache 
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       C. nutans has been traditionally used in Thailand for the treatment of herpes 
infections. Laboratory investigations in Thailand have indicated that the extract of this 
herb exhibits anti-viral properties against the herpes simplex virus (HSV) (Jayavasu et 
al., 1992, Thawaranantha et al., 1992) and varicella zoster virus (VZV) (Jayavasu et 
al., 1992). C. nutans cream was later clinically shown to be as efficacious as acyclovir 
in relieving pain, and healing herpes simplex and herpes zoster without causing a 
burning sensation, the side effect experienced by some patients using acyclovir 
(Jayavasu et al., 1992, Sangkitpporn et al., 1993, Sangkitpporn et al., 1993, 
Charuwichitratana et al., 1996, Jayavasu et al., 1998). 
       Typical C. nutans products are currently being used in many Thai hospitals to 
replace topical acyclovir in treating herpes simplex and herpes zoster. In addition, this 
herb exhibits an excellent and rapid acting, anti-inflammatory property (Chuakul, 
1986, Tanasomwong, 1986, Satayavivad et al., 1996), making a C. nutans topical 
cream or lotion a good natural product for the relief of minor skin inflammation and 
insect bites (Satayavivad et al., 1996). 
       C. nutans has been considered as one of five medicinal plants in the National List 
of Essential Drugs A.D. 1999. It has been promoted for treatment of herpes simplex, 
herpes zoster, and skin pruritis in the Primary Health Care Programme (Minitry of 
Public Health, 1999). 
       Because of its interesting biological activities and the fact that very little is known 
in the literature, it was desirable to phytochemically investigate this plant in detail. 
 
1.2 Specification of Clinacanthus nutans  
       Scientific Name: Clinacanthus nutans (Burm. f.) Lindau. 
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       Family: Acanthaceae.  
       Common Name: Slaed Pang Pon (Tua mia), Phayaa Yo, Phak Man Kai, Phak 
Lin Khiat (Chiang Mai), Phayaa Plong Thong, Phayaa Plong Kham (Lampang),  
Pho-so-chaang (Karen-mae Hong Sorn) (สมิตินันทน, 2544).  
       Botanical Description: This plant is a shrub 1-3 m high with pubescent branches. 
Leaves are simple, opposite, narrowly elliptic oblong or lanceolate, 2.5-13 cm long, 
and 0.5-1.5 cm wide. The leaves have apex acute or acuminate; margin exsculptate-
dentate or subentire; base cuneate, obtuse, rounded or truncate often oblique; 
pubescence on the nerves; petiole 3-15 mm long. Flowers are in dense cymes at the 
top of the branches and their branchlets; cymes 5-α flowered, often terminating 
drooping horizontal branches but themselves erect, subsecund, and combined into a 
large lax, leafy panicle. Each flower has calyx densely patently glandular-pubescent, 
about 1 cm long; corolla glandular-pubescent, about 3.5 cm, dull red with green base; 
lower lip (turned upwards) with yellow streaks, apically sordidly yellow or greenish 
yellow; stamens 2, inserted in the throat, more or less appressed against the upper lip. 
Ovary is compressed, 2-celled, 2 ovules in each cell; having style filiform, shortly 
bidentate. Capsule is oblong, basally contracted into a short, solid stalk 4-seeded 
(Backer et al., 1965, Perry, 1986). Its morphological features are illustrated in Figure 
1.2 and Figure 1.3. 
       Ecology and Distribution: They are cultivated and found in deciduous forests. 
       Propagation: They are normally propagated by cuttings. 
       Loss on Drying: not more than 14%. 
       Total Ash: not more than 21%. 
       Acid-Insoluble Ash: not more than 4%. 
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       Alcohol-Soluble Extract: not less than 27%. 
       Water-Soluble Extract: not less than 26%. 
       Ether-Soluble Extract: not less than 1%. 
       Ethnomedical Use: For the treatment of burn, herpes zoster and insect bite; 
antipyretic (Kharnngan, 1991). 
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Figure 1.2. Morphological features of twig, leave, and flower of Clinacanthus nutans 
(Burm. f.) Lindau. 
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Figure 1.3. Morphological illustration of Clinacanthus nutans (Burm. f.) Lindau. 
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       Chemical Identification 
       1. Warm 0.5 g of the pulverized sample with 2 mL of acetic anhydride on a water 
bath for 2 minutes while shaking, then filter, and to the filtrate add carefully 1 mL of 
sulfuric acid to make two layers: a brownish red color develops at the zone of contact. 
       2. Boil 0.5 g of pulverized sample with 10 mL of water and filter. To 2 mL of the 
filtrate add 1 drop of ferric chloride TS: a brown precipitate is produced. 
       3. Boil 0.5 g of the pulverized sample with 10 mL of water for 2 minutes and 
filter. To 3 mL of the filtrate add 1 mL of Fehling's TS and warm the mixture a brick 
red precipitate is produced. 
       4. Boil 0.5 g of the pulverized sample with 10 mL of water for 2 minutes and 
filter. To 3 mL of the filtrate add a few drops of saturated lead acetate solution. Filter 
the solution when precipitation has completed. Add a few drops of lead subacetate TS 
until neutral or weakly alkaline: a yellow precipitate is produced. 
 
1.3 Pharmacological Study 
       C. nutans has several pharmacological studies as exemplified below: 
       1.3.1 Activity Against Snake Venom  
                A water extract of leaves reduced mortality rate in snake venom treated 
mice from 100% to 63 ± 3.34%, while a 95% alcohol extract (2.0 g/kg) was 
ineffective when injected intravenously, intraperitoneally, or given orally (Thongharb 
et al., 1977). A water extract was also effective in counteracting snake venom when 
tested on rat phrenic nerve diaphram preparation (Cherdchu et al., 1977). 
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       1.3.2 Antiinflammatory Activity 
                Leaf extracts, especially a butanol extract, reduced inflammation induced by 
carrageenin injection in rats. The active fraction was reported to be unstable. One of 
the active ingredients in C. nutans was identified as a flavonoid compound (Chuakul, 
1986, Tanasomwong, 1986, Satayavivad et al., 1996). 
 
       1.3.3 Activity Against Herpes Simplex Virus (HSV) 
                In 1992 Jayavasu et al. and Thawaranantha et al. reported the ability of the 
ethanol extract of C. nutans leaves to inactivate HSV-2 compared with that of 
acyclovir. The activity was measured in vitro using a plaque reduction assay of HSV-
2 in baby hamster kidney cell line. Based on 50 percent inhibited dose, the results 
showed the ethanol extract of C. nutans leaves inhibited plaque formation by HSV-2.  
                In 1992 Jayavasu et al. reported the clinical trial in the treatment of genital 
herpes patients with C. nutans extract, it showed that patients who used C. nutans as 
well as those who used acyclovir, could develop crust lesion within 3 days and 
healing within 7 days while the placebo group had crusting time in 4-7 days and 
healing time in 7-14 days or more. This meant that C. nutans and acyclovir have good 
efficacy in shortening the duration of infection and reducing severity. Besides, C. 
nutans has no sticky, burning, stinging pain and side effects. In conclusion, it is 
believed that C. nutans is suitable for the treatment of genital herpes patients. 
                In 1993 Sangkitporn et al. reported the results of treatment of recurrent 
Genital Herpes Simplex virus infection with C. nutans extract, the numbers of patients 
with lesion crusting within three days and with lesion crusting within seven days were 
significantly increased in the C. nutans extract-treated group and the acyclovir-treated 
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group compared with the placebo-treated group. There was no side effect of C. nutans 
during treatment. Mild, transient burning or pains associated with application of 
acyclovir were found in 21 male patients (24.7%) and in 18 female patients (23.1%). 
 
       1.3.4 Activity Against Varicella Zoster Virus (VZV) 
                In 1992 Jayavasu et al. reported the ability of the extract of C. nutans leaves 
to inactivate VZV. The activity was measured in vitro using a plaque reduction assay 
and DNA hybridization. Based on 50 percent inhibited dose, the results showed the 
extract of C. nutans leaves inhibited plaque formation by VZV. From the present 
findings, based on the result of inactivation assay, it was recognized that the in vitro 
antiviral activity of C. nutans might be a direct interaction of the extract with the 
virus.  
                In 1993 Sangkitporn et al. reported the results of treatment of herpes zoster 
with a topical formulation of 5 percent C. nutans extract. There was no difference of 
patient characteristics in the C. nutans extract-treated group and in the placebo group, 
but the numbers of patients with lesion crusting within three days and healing within 
seven days and ten days were significantly greater in the C. nutans extract-treated 
group than in the placebo group. Fourthermore, the pain score was reduced more 
rapidly in the C. nutans extract-treated group, and there were no side effects from the 
study medication. C. nutans cream is more effective than placebo in the treatment of 
herpes zoster and the patients healed faster than patients in the placebo group 
(Charuwichitratana et al., 1996). 
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       1.3.5 Toxicological Study 
                Acute toxicity studies of ethanolic extract of C. nutans leaves given orally, 
subcutaneously, or intraperitoneally, did not produce any side effects of toxicity in the 
animal.  
                A subchronic toxicity study was performed by daily oral administration of 
the extract to rats for 90 days. Histopathalogical examination of internal organs did 
not show any abnormalities that could be due to the effect of the extract 
(Chavalittumrong et al., 1995). In addition ethanol extract of C. nutans was shown to 
inhibit growth of yellow head baculoving and also to induce phagocytosis activity in 
tiger prawn (Chavalittumrong et al., 1995). The results of these studies shows that C. 
nutans has strong potential to be developed as a novel source of medicine to treat 
herpes infections.  
                The Department of Medical Sciences, Ministry of Public Health transferred 
the technology of C. nutans antiviral cream, including extraction and the formulation 
of C. nutans cream, to the Government Pharmaceutical Organization to produce this 
cream for the market (Jayavasu et al., 1998). This case illustrates that traditional 
medicine can be very valuable and useful for modern scientific studies. 
                Consequently, a systematic procedure for the quality control of the crude 
drug and raw material has to be established. Currently, the control of C. nutans to 
produce antiviral cream uses a bioactivity test (plaque reduction assay) which requires 
considerable time and cost. As it is important to reduce the cost of such control, 
chemical study of active components should be conducted to obtain the quality 
control of crude extract of C. nutans by developing chemical reference standards for 
the active components isolated from C. nutans.  
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1.4 Chemical Constituents 
       C. nutans has been chemically investigated previously as below: 
       In 1976 and 1977 Dampawan et al. reported the isolation of stigmasterol (5), 
lupeol (6), and β-sitosterol (7) from a light petroleum extract of the leaves, stems, and 
roots of C. nutans. 
 
HO
RO
HH
 
                            (5)                                                                    (6) 
 
HO  
                                                                  (7) 
       In 1983, Lin et al. reported the isolation of betulin (8), lupeol, and β-sitosterol 
from the roots of C. nutans. 
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       Although chemical studies were started in 1976, very little advance was made at 
that time, because of unsystematic approaches in the isolation and lack of suitable 
techniques for the characterization of the components. Howerver, as a result of the 
development in instrumental and chemical techniques, in 1997 Teshima et al. isolated 
six known C-glucosyl flavones, (vitexin (9), isovitexin (10), shaftoside (11), 
isomollupentin-7-0-β-glucopyranoside (12), orientin (13), and isoorientin (14)) from 
the methanol extract of the stems and leaves of C. nutans. 
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       In 1998 Teshima et al. isolated five sulfur-containing glucosides, (clinacoside A 
(15), clinacoside B (16), clinacoside C (17), cycloclinacoside A1 (18), and 
cycloclinacoside A2 (19)) from the butanol and water soluble portions of the 
methanol extract of the stems and leaves of C. nutans.  
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       In 2001 Satakhum et al. reported the isolation of two glycoglycerolipids (1,2-O-
dilinolenoyl-3-O-β-D-galactopyranosyl-glycerol (20) and 1-O-palmitoyl-2-O-
linolenoyl-3-O-[α-D-galactopyranosyl-(1" 6')-O-β-D-galacctopyranosyl]-glycerol 
(21)) from the leaves of C. nutans. Further investigation by Suwanborirux et al. in 
2003 found anti-HSV activity of both compounds (Suwanborirux et al., 2003). 
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      In 2004 Tuntiwachwuttikul et al. 
cerebrosides (22) and a monoacylmono
nutans. The structures of the cerebrosid
of phytosphingosines, which comprised
2-amino-8(Z)-octadecene-1,3,4-triol wit
lengths (C16, C18, C20-26) linked to 
characterized as (2S)-1-O-linolenoyl-3-O                   R1                                      R2
Major Hexadecanoyl (16:0)  Hexadecatrienoyl (16:3) 
           Octadecanoyl (18:0)   Hexadecatrienoyl (16:3)
Minor Hexadecanoyl (16:0)  Octadecanoyl (18:0) 
           Octadecanoyl (18:0)   Hexadecanoyl (16:0) O
OR1
OR2   
(20) 
O
O
OR1
OR2
OH
 
          R1                                      R2
r Octadecanoyl (18:0)           Octadecatetraenoyl (18:4)  
  Octadecatetraenoyl (18: 4) Octaadecanoyl (18: 0) 
r Hexadecanoyl (16:0)          Octadecatrienoyl (18:3) 
(21) 
reported the isolation of a mixture of nine 
galactosylglycerol (23) from the leaves of C. 
es were characterized as 1-O-b-D-glucosides 
 a common long-chain base, (2S, 3S, 4R, 8Z)-
h nine 2-hydroxy fatty acids of varying chain 
the amino group. The glycosylglyceride was 
-b-D-galactopyranosylglycerol. 
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      Although the chemical constituents have been reported, the active components 
have not been identified. This project, attempts to isolate and characterize such 
chemical principles of C. nutans. Further studies on antiviral activity against HSV-2 
of the isolated compounds should also be conducted. 
      Our research group has been interested in this plant due to wide use in traditional 
medicine. Because of its interesting biological activities, and the fact that very little is 
known about it in the literature, it was desirable to phytochemically investigate this 
plant in detail. 
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       In this project, ten compounds were separated from the leaves of C. nutans. Three 
of the isolated compounds could be identified as chlorophyll a and chlorophyll b 
related compounds. Structures of isolated compounds were characterized on the basis 
of NMR spectra by comparison of their NMR spectral data with literature values. 
       Details on isolation and structure determination of chemical constituents will be 
discussed in the next section of this thesis. 
       Thus, the objectives of this research were as follows: 
       1. To extract and isolate chemical constituents from the leaves of C. nutans. 
       2. To identify the structural formula of the isolated substances. 
CHAPTER II 
CONCEPTS AND THEORETICAL BACKGROUND 
 
      Despite the availability of a number of modern efficacious drugs, herbal medicines 
are still widely used and their importance is increasing because of the presence of 
certain incurable diseases such as AIDS and some chronic diseases. It is well known that 
any agent intended to be used as a drug should be uniform in quality regarding origin, 
the content of therapeutically active constituents, and cleanliness. Many herbal 
medicines being sold in the market are fake products. Some medicinal plant materials 
are sold under the same local name but derived from different origins; hence, their 
curative effects are different and some may even lead to toxicity. The natural variations 
of active constituents in herbal materials are also vital to the efficacy of herbal 
medicines. Besides, these drugs are often contaminated with microorganisms, which 
may cause various infections to consumers. To overcome the risk of the possible health 
hazards mentioned above, standard specifications and quality control procedures for 
these medicines are required by manufacturers as well as by regulatory authorities to 
improve the image of herbal medicinal products (Dechatiwongse na Ayudhaya, 1997). 
 
2.1 Importance of Standardization and Quality Control 
      There are some important factors affecting the efficacy and safety of medicinal plant 
materials, namely: (Dechatiwongse na Ayudhaya, 1997 and Chavalittumrong et al., 
2000). 
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      2.1.1 Plant Name There are some difficulties with the plant names because some 
plants have the same local name but belong to different botanical origins or vice versa. 
If wrong medicinal plant materials are used, they will possess not only undesirable 
activities, but also may have unexpected toxicities. 
 
      2.1.2 Part Used The right part of a plant should be used. Different parts generally 
contain different substances. 
 
      2.1.3 Age The proper harvesting time for medicinal plants should be known to 
obtain high content of therapeutic principles. 
 
      2.1.4 Preparation and Storage The suitable processes of cleaning, cutting, drying 
and preservation should be followed to prevent the contamination, or deterioration of 
crude plant materials. 
 
      2.1.5 Quality Though we know the correct plant name, the right part used, the 
proper harvesting time, suitable process of preparation and storage, we still cannot 
assume that raw materials of high quality can be obtained. Chemical constituents of 
plants are usually affected by external factors; e.g. climate, the physical features of the 
land, irrigation, fertilizer, etc. 
      Hence, it is essential to set up scientific criteria for standardization and quality 
control of herbal medicines to ensure that the consumers receive drugs of high quality. 
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2.2 General Control Methods 
      The standard control of herbal remedies is performed by 2 aspects (Dechatiwongse 
na Ayudhaya, 1997, and Chavalittumrong et al., 2000, 2001, and 2002). 
      2.2.1 Establishment of Standard Specifications of Herbal Raw Materials  
               According to World Health Organization (WHO) documents and other useful 
information, the specifications for medicinal plant materials should include the 
following: 
               1. Name (Scientific Name, English Name, Local Name) 
               2. Synonyms 
               3. Definition 
               4. Constituents 
               5. Plant Description 
               6. Description of Plant Material 
                   6.1.   General Appearance 
                   6.2.   Organoleptic Properties 
                   6.3.   Microscopic Characteristics 
               7. Packaging and Storage 
               8. Identification 
                   8.1.   Chemical Reaction 
                   8.2.   Thin-Layer Chromatographic Analysis 
               9. Purity Tests 
                   9.1.   Microbiological 
                   9.2.   Foreign Matter 
                   9.3.   Total Ash 
                   9.4.   Acid-Insoluble Ash 
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                   9.5.   Water-Soluble Extract 
                   9.6.   Alcohol-Soluble Extract 
                   9.7.   Moisture 
                   9.8.   Pesticide Residues 
                   9.9.   Arsenic and Heavy Metals 
                   9.10. Radioactive Residues 
               10. Determination of Major/Active Chemical Constituents 
               11. Medical Uses and Doses 
 
      2.2.2 Development of Good Manufacturing Practice (GMP) Guidelines for the 
               Manufacture of Herbal Medicinal Products 
               The purpose of these guidelines is to outline steps which should be taken, as 
necessary and appropriate, by manufacturers of herbal medicinal products with the 
objective of ensuring that their products are of the nature and quality intended. 
Successful and concurrent implementation of these GMP guidelines will not only 
improve the image of the herbal medicinal products industry, but also promote 
international recognition and acceptance and consequently, escalate the export potential 
of these products. The Good Manufacturing Practices for Pharmaceutical Products, 
Supplementary guidelines for the manufacture of herbal medicinal products, 
WHO/Pharm/93.561 (Lou, 1993) should be followed to develop the above mentioned 
guidelines. 
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2.3 Quality Assurance and Regulatory Control of Herbal Medicines in 
       Thailand 
        Medicinal plants have been used in Thailand for a long period of time. 
Documentarily, the first record appeared during the Sukothai period (14th century A.D.) 
and the use of traditional drug formulas began during the Ayudhya period. Traditional 
drugs have been popular in the Kingdom throughout the Ayudhya and Rattanokosin 
periods. King Rama III (about 200 years ago) ordered the collection of traditional drug 
formulas including the diagnosis of diseases, traditional massage, literature and poetry, 
and their subsequent inscription on stone plates installed on the walls of two temples 
(Wat Po and Wat Raja Orasa Ram). Again during the years 1895-1900 King Rama V 
ordered the collection of all knowledge of traditional medicine from the noble sand 
doctors, and the printing and distribution for the first time in the two volumes of the 
official pharmacopoeia called "Tamrapaettayasartsongkroh". Since the use of herbal 
medicines is quite often derived from empirical experience, the standardization and 
quality control of these preparations are usually lacking, which hamper an increased 
utilization of such medicines. Thai pharmacists and scientists have therefore realized 
that this problem should be solved to upgrade the quality of herbal raw materials and 
their finished products (Dechatiwongse na Ayudhaya 1997). 
        Generally, the term "herbal medicines" applies to medicinal products whose active 
ingredients consist exclusively of plant materials, or vegetable drug preparations. This 
notion of herbal remedies has broad international recognition since WHO has defined 
the term in the same way. 
        The chemistry of medicinal herbs is very complex. Not all the constituents present 
in the plant have therapeutic activity, some are poisonous e.g. pyrrolizidine and tropane 
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alkaloids. Phytochemistry deals with the study of the chemical composition of plant 
material. Plants are used in various forms varying from powders to extracts. Powder 
represents the drug in ground form and these types of preparations are considered to be 
crude. The Pharmacopoeia mentions standardized vegetable powders for therapeutic 
application (Sawasdimongkol, 1995). 
        Herbal systems of medicine have become increasingly popular in recent years. A 
recent study from America demonstrated that about 34% of the general population used 
one or the other system at least once a year. In India 76% of patients visiting the general 
medicine OPD of a tertiary care hospital use alternative therapies. In light of growing 
demand for herbal drugs, the quality control and assurance is primarily important. The 
standardized herbal extracts are considered to be more scientific than crude drugs. The 
commonly employed technique for removal of active substances from the crude drug is 
called extraction. Selection of the solvent is very critical in preparing extracts, because 
the active constituent of the plants have affinity for solvents.  
        Extracts are prepared by separating the soluble matter from vegetable tissues by 
application of a suitable solvent like alcohol, water, or ether. The resultant liquid is 
concentrated by evaporation to obtain liquid extract, or concentrated nearly to dryness to 
obtain solid extract. Depending on the solvent used, the extracts are classified as 
alcoholic, ethereal, or aqueous (the solid and liquid extract classification is based on 
method of preparation, the alcoholic, aqueous, and ethereal extract classification is 
based on type of solvent used) (Pothisiri, 1996). 
        The standardized herbal extract is a preparation, which contains a certain fixed 
proportion of the active constituent. For example, a standardized extract of Papaver 
somniferum contains not less than 9.5% of morphine. The concept of standardization has 
great impact on the quality of herbal products. Standardization helps in adjusting the 
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herbal drug formulation to a defined content of a constituent or constituents with 
therapeutic activity. The latest method of preparing herbal extracts is by successive 
macerating of the powdered drug in order of increasing polarity. This process is known 
as successive solvent extraction and is carried out in a special assembly known as a 
Soxhlet apparatus. The biological source of the drug has great impact on the finished 
product in herbal drug preparation. Proper identification of the drug is significant for 
phytochemical screening, which further exerts importance on therapeutic activity of the 
medicinal herb. Thus, presence of an identification standard is a must in the finished 
product of an herbal drug preparation. A constituent of a medicinal herb, which is used 
for quality control and assurance of a herbal product, is known as a marker compound. 
A marker compound may or may not have therapeutic activity. Commonly used herbal 
extracts are listed in Table 2.1 (Sawasdimongkol, 1995 and Malhotra et al., 2002). 
 
Table 2.1. Report on Some Medicinal Standards. 
Botanical Name Standard Percentage 
  1. Achellia Millefolium 
  2. Adhatoda Vasica 
  3. Allium Sativum 
  4. Andrographis Paniculata  
  5. Asparagus Racemosus 
  6. Azadirachita Indica 
  7. Bacopa Monneri 
  8. Boswellia Seratta Acid. 
  9. Camelia Sinensis 
Essential oil 
Vasicine 
Allicin 
Andrographolide 
Saponin 
Azadiractin 
Bacoside 
Boswellic 
Epigallocatechin Gallate 
0.04% 
0.5% 
0.6% 
10% 
30% 
2% 
20% 
40% &70% 
0.2% 
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Table 2.1. (Continued). 
Botanical Name Standard Percentage 
10. Capsicum Frutescens 
11. Centella Asiatica 
12. Cholorella Emersoni 
13. Commiphora Balsamdendron 
      Mukul 
14. Cratageus Oxycanthus 
15. Curcuma Longa 
16. Cynara Scolymus 
17. Echinacea Angustifolia 
18. Embelia Ribes 
16. Cynara Scolymus 
17. Echinacea Angustifolia 
18. Embelia Ribes 
19. Ephedra Sinica 
20. Garcinia Cambogia  
21. Ginkgo Biloba  
22. Glycyrrihiza Glabra  
23. Gymnema Sylvestre  
24. Hydrastis Canadensis 
25. Hypericum Perforatum  
26. Huperzia Serrata  
27. Momordica Charantia  
Capsaicinoids 
Asiaticoside 
Chlorophyll 
Guggulsterones 
 
Vitexin 
Curcumin 
Cynarin 
Echinacosides 
Embellin 
Cynarin 
Echinacosides 
Embellin 
Ephedrine 
Hydroxy Cirtic Acid 
Flavonoglycosides 
Glycyrrhizin 
Gymnemic Acid. 
Alkaloids 
Hypericin 
Huperzine 
Bitters 
0.62% 
3% 
1% 
5% 
 
5% 
95% 
1% 
4% 
8% 
1% 
4% 
8% 
6% 
50% 
24% 
20% 
75% 
3% 
0.3% 
5% 
3% 
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Table 2.1. (Continued). 
Botanical Name Standard Percentage 
28. Ocimum Sanactum  
29. Passiflora Incarnata  
30. Phylanthus Niruri  
31. Picrorrhiza Kurroa  
32. Piper Methysticum  
33. Pueraria Tuberosa  
34. Saraca Indica  
35. Sereno Repens  
36. Shilajit  
37. Silybum Marianum 
38. Spirulina Maxima  
39. Terminalia Arjuna 
40. Terminalia Belerica 
41. Terminelia Chebula  
42. Tribulus Terrestris  
43. Trigonella Foenum  
44. Triphla  
45. Uncaria Tomentosa  
46. Valeriania Officinalis  
47. Vitis Vinifera  
48. Withania Somnifera  
49. Zingiber Officinale 
Ursolic Acid 
Vitexin 
Bitters 
Kutkosides 
Kavalactones 
Disogenin 
Tannins 
Fatty acids 
Fulvic acid 
Silymarin 
Phycocyanin 
Tannins 
Tannins 
Tannins 
Saponin 
Graecum Saponin 
Tannins 
Saponins 
Valerenic acid. 
Proanthocyanidins 
Withanolides 
Gingerols 
8% 
4% 
2% 
10% 
30% 
7% 
8% 
20-25% 
50% 
70% 
2.5% 
8% 
40% 
60% 
20% & 40% 
10% 
40% 
2% 
0.8% 
95% 
1.5% 
5% 
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        Nowadays, we talk about active constituents of phyto drugs. An active constituent 
is truly responsible for therapeutic activity of a medicinal plant. The extracts are further 
subjected to chemical tests for identification of the plant constituents. The isolated 
constituents are of further importance to the pharmaceutical industry for applied 
research.  
 
2.4 Extraction and Isolation  
       2.4.1 Extraction Theory and Procedure 
                Extraction is a very common laboratory procedure for isolating or purifying a 
product. Organic chemists employ solid-liquid, liquid-liquid, and acid-base extractions. 
The following applies to solid-liquid extractions, which was be used for this thesis. 
                A solid-liquid extraction is often used to extract solid natural products from a 
natural source, such as a plant. A continuous solid-liquid extraction apparatus, called a 
Soxhlet extractor, is illustrated in Figure 2.1 (Wingrove et al. 1981). 
 
 Condenser 
 
 
Siphon 
 
 
Extraction Thimble 
Solid Sample
 
Extracting 
Solvent 
 
 
 
Figure 2.1. Soxhlet extraction apparatus. 
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                As shown in Figure 2.1, the sample is put into a Soxhlet thimble which is held 
within the extraction apparatus. The solvent in the distillation flask is refluxed, and the 
condensed vapor collects within the soxhlet thimble, where it interacts with the sample. 
The solvent plus extract eventually siphons back into the distillation flask. This process 
continues until extraction is complete.  
                Chemical composition of medicinal herbs is always a complex subject. 
Studying one substance among many is often difficult. Consequently, a number of 
techniques to separate complex mixtures into their individual components have been 
developed. Collectively, we call these methodologies chromatographic separation 
techniques;  
                Separation techniques allow individual substances to be isolated and studied. 
For example, once chlorophyll a and chlorophyll b were isolated using chromatography, 
the differences in their structures could be determined. A further use of separation 
techniques is for identification purposes. The principle behind the use of a separation 
technique for identification is that a substance will always behave the same way if it is 
treated identically, and one can know what it is by how it behaves.  
 
       2.4.2 Chromatography Theory 
                The separation of the components of a mixture by chromatography involves a 
stationary phase (chromatographic support) through which a mobile phase 
(chromatographic solvent) is flowing. When a mixture is applied to the stationary phase 
and allowed to flow with the mobile phase, the various components of the mixture move 
at different relative rates. These differences in rates of movement are a function of their 
relative affinities for the stationary phase and the mobile phase. For instance, if 
substance A has a high affinity for the stationary phase and a low affinity for the mobile 
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phase, it will move slowly, or not at all, as the mobile phase flows over the stationary 
phase. Conversely, if substance B has high affinity for the mobile phase but a low 
affinity for the stationary phase, it will move rapidly (Wade, 1987).  
 
                2.4.2.1 Thin Layer Chromatography 
                            Thin Layer Chromatography (TLC) is a solid-liquid technique in 
which the two phases are a solid (stationary phase) and a liquid (moving phase). Solids 
most commonly used in chromatography are silica gel (SiO2.x H2O) and alumina 
(Al2O3.x H2O). Both of these adsorbents are polar, but alumina is more so. Silica is also 
acidic. Alumina is available in neutral, basic, or acidic forms. Thin Layer 
Chromatography (TLC) is a sensitive, fast, simple and inexpensive analytical technique. 
It is a micro technique; as little as one ng of material can be detected, although the 
sample size is from 1-100 µg. TLC involves spotting the sample to be analyzed near one 
end of a sheet of glass or plastic that is coated with a thin layer of an adsorbent. The 
sheet, which can be the size of a microscope slide, is placed on end in a covered jar 
containing a shallow layer of solvent. As the solvent rises by capillary action up through 
the adsorbent, differential partitioning occurs between the components of the mixture 
dissolved in the solvent the stationary adsorbent phase. The more strongly a given 
component of a mixture is adsorbed onto the stationary phase, the less time it will spend 
in the mobile phase and the more slowly it will migrate up the plate. 
                            A spot or line of the mixture to be separated is applied at one end of a 
piece of the stationary phase. Then the chromatogram is developed by allowing the 
mobile phase to flow up by capillarity or down by gravity. After the mobile phase has 
reached the opposite end of the sheet of paper or thin layer medium, the chromatogram 
is removed from the mobile phase, the level to which the solvent has moved is marked 
 35
and the medium is dried. Each component of the mixture will have moved to a different 
level and some may not have moved at all. The ratio of the distance traveled by the 
solute (mixture component) to that of the solvent (mobile phase) is known as the Rf 
(retardation factor or flow rate) value.  
 
                                                    solute distance from origin    
(1) 
Rf      = 
                                                    solvent distance from origin 
 
                            If all conditions are kept the same (temperature, solvent system, nature 
of stationary phase, direction of flow, etc.), the Rf value is a characteristic of the solute 
and may be used to identify it. For identification of a mixture component, the unknown 
is chromatographed with a series of compounds of known identity and the Rf values 
compared. This is called co-chromatography (Pine, 1987). 
 
                2.4.2.2 Column Chromatography 
                            In column chromatography, the stationary phase, a solid adsorbent, is 
placed in a vertical glass (usually) column and the mobile phase, a liquid, is added to the 
top and flows down through the column (by either gravity or external pressure). Column 
chromatography is generally used as a purification technique to isolate desired 
compounds from a mixture. The mixture to be analyzed by column chromatrography is 
applied to the top of the column. The liquid solvent (the eluent) is passed through the 
column by gravity or by the application of air pressure. An equilibrium is established 
between the solute adsorbed on the adsorbent and the eluting solvent flowing down 
through the column. Because the different components in the mixture have different 
interactions with the stationary and mobile phases, they will be carried along with the 
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mobile phase to varying degrees and a separation will be achieved. The individual 
components, or eluents, are collected as the solvent drips from the bottom of the 
column. The polarity of the solvent which is passed through the column affects the 
relative rates at which compounds move through the column. Polar solvents can more 
effectively compete with the polar molecules of a mixture for the polar sites on the 
adsorbent surface and will also better solvate the polar constituents. Consequently, a 
highly polar solvent will move even highly polar molecules rapidly through the column. 
If a solvent is too polar, movement becomes too rapid, and little or no separation of the 
components of a mixture will result. If a solvent is not polar enough, no compounds will 
elute from the column. Proper choice of an eluting solvent is thus crucial to the 
successful application of column chromatography as a separation technique. TLC is 
generally used to determine the system for a column chromatography separation (Pine, 
1987). 
 
                2.4.2.3 Determining Solvent Systems for Thin Layer Chromatography  
                             and Column Chromatography 
                             For determing the best system to develop a TLC plate or 
chromatography column loaded with an unknown mixture, vary the polarity of the 
solvent in several trial runs. Carefully observe and record the results of the 
chromatography in each solvent system. When increasing the polarity of the solvent 
system, all the components of the mixture move faster. The ideal solvent system is 
simply the system that separates the components. 
                             TLC elution patterns usually extrapolate to column chromatography 
elution patterns. Since TLC is a much faster procedure than column chromatography, 
TLC is often used to determine the best solvent system for column chromatography. For 
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instance, in determining the solvent system for a flash chromatography procedure, the 
ideal system is the one that moves the desired component of the mixture to a TLC Rf of 
0.25-0.35 and will separate this component from its nearest neighbor by difference in 
TLC Rf values of at least 0.20. Therefore, a mixture is analyzed by TLC to determine 
the ideal solvent(s) for a flash chromatography procedure. 
                            Because of toxicity, cost, and flammability concerns, the common 
solvents are hexanes (or petroleum ethers) and ethyl acetate (an ester). Diethyl ether can 
be used, but it is very flammable and volatile. Alcohols (methanol, ethanol) can be used. 
Acetic acid (a carboxylic acid) can be used, usually as a small percentage component of 
the system, since it is corrosive, nonvolatile, very polar, and has irritating vapors. 
Acetone (a ketone) can be used. Methylene chloride (halogenated hydrocarbon) is a 
good solvent, but it is toxic and should be avoided whenever possible. If two solvents 
are equal in performance and toxicity, the more volatile solvent is preferred in column 
chromatography because it will be easier to remove from the desired compound after 
isolation from a column chromatography procedure. The scheme below should help in 
solvent selection (Pine, 1987 and Wade, 1987). 
 
d 
 
 
 
Increasing polarity 
move more slowly 
 
 
 
 
Scheme 2.1. The expected elution order of or
 alkanes (hexanes, petroleum ether) 
ethers, toluene 
halogenated hydrocarbons  
aromatic hydrocarbons 
aldehydes and ketones 
diethyl ether, acetone, alcohols, acetic aciganic classes. 
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2.5 Structure Elucidation 
        2.5.1 Nuclear Magnetic Resonance (NMR) Spectroscopy 
                 Nuclear magnetic resonance was first observed in 1946. Bloch and Purcell 
were jointly awarded the 1952 Nobel Prize for physics for their discovery. Also, the 
Nobel Prize for chemistry awarded in 1991 to Ernst of the ETH Zurich. The main 
application of NMR is in determining the structures of molecules. It is a very powerful 
tool for doing this and as such, has become, possibly, the most important of all 
spectroscopic methods. 
 
                 2.5.1.1 1-D NMR Spectroscopy 
                             1-D NMR was the only technique used until the 1970’s, i.e. the 
spectrum has 2 axes, plotting frequency against intensity. Some of these techniques, 
often employing complex pulse sequences to obtain specific information, are still very 
useful in determining structures from spectra. Some of these are summarized below: 
 
Table 2.2. Multiple Pulse 1-D NMR Techniques. 
Experiment Nuclei Observed Types of Information, Applications 
J-modulated spin-echo 
(attached proton test, 
APT) 
13C CH and CH3 carbon nuclei give 
positive signals, 4° and CH2 carbons 
give negative signals. An aid to 
assignment. 
INEPT 1H / 13C The INEPT pulse sequence is used 
as a component of many 2-D 
experiments e.g. HSQC. 
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Table 2.2. (Continued). 
Experiment Nuclei Observed Types of Information, Applications 
DEPT 13C Tells how many hydrogen atoms are 
directly bonded to a carbon nucleus: 
CH, CH2, CH3. Disadvantage: no 
signals from 4° carbon atoms. 
Selective TOCSY 1H Allows identification of all the 
protons belonging to a common 
coupled spin system. 
1D-INADEQUATE 13C Exact 13C-13C coupling constants 
without the need to synthesise 13C 
enriched compounds. 
 
                 2.5.1.2 2-D NMR Spectroscopy 
                             A 2-D spectrum is a spectrum in which both axes show chemical 
shifts, with the intensity of the peaks constituting a third dimension. This gives a 
contour plot. From a practical point of view, the most useful 2-D spectra are those that 
show either 1H-1H correlations or 1H-13C correlations. 
                             2-D methods are based on the couplings between nuclear dipoles. 
These can be scalar (through bond) couplings, or of a dipolar type (through space, as in 
the nuclear overhauser effect). 
                             In a normal pulsed NMR experiment, the excitation pulse is followed 
immediately by the data acquisition (detection) phase, in which the free induction decay, 
FID, is recorded and the data stored. In the specialised 1-D NMR techniques described 
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above, the spin system undergoes a preparation phase before data acquisition. In 2-D 
NMR experiments, these two phases are separated by a third phase, that of evolution and 
mixing. 
 
Table 2.3. Two-Dimensional NMR Techniques. 
Experiment Nuclei Observed Types of Information, Applications 
Heteronuclear J-resolved 
13C NMR spectroscopy 
13C 13C-1H coupling constants, number 
of directly bonded protons (as in 
DEPT). 
Homonuclear J-resolved 
1H NMR spectroscopy 
1H Useful in determining chemical shift 
values in complicated spectra, 
identifying peaks of multiplets. 
1H-1H COSY 1H Assigning signals in complicated 
spectra. 
Long-range COSY 1H Assigning signals of protons 
separated by four or more bonds 
where the couplings are small. 
1H-13C COSY (HMQC, 
Heteronuclear Multiple 
Quantum Coherence) 
1H, 13C Assigning signals in proton and 
carbon spectra, starting from known 
signals. 
HMBC (Heteronuclear 
Multiple Bond 
Correlation) 
1H, 13C Assigning 1H and 13C signals on the 
basis of long range couplings. 
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Table 2.3. (Continue). 
Experiment Nuclei Observed Types of Information, Applications 
2-D TOCSY 1H Allows identification of all the 
protons belongng to a common 
coupled spin system. 
NOESY 1H Gives evidence for spatial proximity 
of nuclei using nuclear Overhauser 
effect. 
EXSY 1H Qualitative evidence of exchange 
processes. 
2-D INADEQUATE 13C Assigning signals by detecting 
couplings between adjacent 13C 
nuclei. 
 
                             Assignment of peaks from correlated NMR spectroscopy (COSY, 
HMBC, HMQC, TOCSY, NOESY), results in many assignment problems, which can be 
solved in an elegant way with the help of 2-D correlated NMR spectroscopy. This is by 
far the most important form of 2-D NMR (Breitmaier, 1993). 
 
                 2.5.1.3 Overview of the COSY Experiment 
                             Pulse sequence; consists of a variable delay time, t1, and acquisition 
time, t2. The experiment is repeated many times with different values of t1 and the data 
acquired during t2 is stored in a computer. The value of t1 is steadily increased 
throughout the experiment. During a typical experiment, something on the order of a 
thousand individual FID patterns, each incremented in t1, must be recorded. This takes 
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approximately 30 minutes, longer for higher field instruments (500 MHz and above). 
The results of these are processed as summarized below. 
      1. After an initial relaxation delay, a radio frequency pulse prepares the system by 
rotating the bulk magnetization vectors of the nuclei by 90°. 
      2. This is the variable delay period, t1. During this period, the spins evolve i.e. they 
relax under the influences of chemical shift and mutual spin-spin coupling. 
      3. At the end of this evolution period, a second 90° pulse is applied – this constitutes 
the mixing period. This has the effect of distributing the magnetization among the 
various spin states of the coupled nuclei. Magnetization that has been encoded by 
chemical shift during t1 can then be detected at other chemical shifts during t2, resulting 
in diagonal cross-peaks in the 2-D plot. This means that the cross-peaks show the 
correlation of pairs of nuclei by means of their spin-spin coupling. In the COSY 
spectrum of a complete molecule, the result is a complete description of the coupling 
partners in the molecule. 
 
                 2.5.1.4 Overview of Heteronuclear Correlated (HETCOR) Spectroscopy 
                             Methods (HSQC, HMQC, HMBC) 
                             As before, the magnetization vectors of the protons are allowed to 
relax at different rates according to their chemical shifts. This is done in the same way 
as for COSY, i.e. a 90° pulse followed by an evolution time t1. After t1, a 90° pulse is 
applied to both the protons and the carbons. This transfers magnetization from protons 
to carbons. Since the carbon magnetization was ‘labeled’ by the proton precession 
frequencies during t1, the 13C signals that are detected during t2 are modulated by the 
chemical shifts of the coupled protons. The 13C magnetization can then be detected in t2 
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to identify a particular carbon carrying each type of proton modulation. What all this 
means is that in the techniques HSQC and HMQC we end up with a spectrum that 
shows the 1H and 13C spectra plotted against each other. Cross peaks occur where a 
proton chemical shift value corresponds to a proton which is attached to a 13C nucleus 
which appears at its own carbon chemical shift value. Of the three techniques, HMQC is 
by far the most common, and useful. HMBC enables assignments of signals in cases 
where 13C and 1H nuclei are coupled through two or more bonds. 
 
                 2.5.1.5 Overview of Nuclear Overhauser Effect Spectroscopy (NOESY) 
                             NOE is a phenomenon involving polarization transfer between nuclei 
which do not have scalar (through bond) couplings, but are close together in space. 
(Ideally the nuclei being observed should be 3-5 Å apart.) This can be achieved by 
selective saturation of a particular signal, then watching for effects on other peaks in the 
1-D spectrum. However, a much more satisfactory way of observing magnetization 
transfer to other nuclei is by 2-D NOESY. The pulse sequence for this experiment 
consists of three 90° pulses, the second and third of which are separated by a fixed delay 
τm in which magnetization is transferred between neighboring spins via the NOE. The 
result of this is a 2-D spectrum with cross peaks whose intensity depends on the 
efficiency of the transfer of magnetization between the two spins during τm. There are 
also diagonal peaks as in COSY, since the spins always have some magnetization left at 
the end of τm. The experiment works in exactly the same way in the event of a scalar 
coupling between two nuclei. 
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        2.5.2 Structural Analysis on the Basis of NMR Parameters 
                 The focus in the following three sections is on the analysis of the solution 
conformations of organic molecules utilizing NMR parameters, i.e. chemical shift, 
scalar coupling, and NOE. 
 
                 2.5.2.1 Chemical Shift 
                             There exists a great amount of tabular data in the NMR literature, 
according to which the chemical shift of a nucleus is indicative of a specific chemical 
structure. There are some computer programs available which can predict the chemical 
shift of a certain nucleus that is part of a defined structural subunit. However, chemical 
shifts provide information not only about the chemical structure of the molecule being 
studied, but also about its surroundings. Since the chemical shift of a nucleus depends 
on the local magnetic field around it, δ is affected by magnetic and electrostatic effects 
exerted by the surroundings of the nucleus. One example of this is the magnetic 
anisotropic effect of a neighbouring group, which can lead to a shielding or deshielding 
of the nucleus. In practice, δ-values of protons are the most sensitive for detecting 
anisotropy effects of molecular surroundings in organic compounds. Typical shielding 
or deshielding cones for groups of common anisotropy sources in organic molecules are 
depicted in Figure 2.2. The magnetic susceptibilities of the chemical bond, e.g. a 
carbonyl group and a carbon-carbon double bond, lead to the magnetic anisotropy effect 
in an external B0-field. In aromatic compounds, such as benzene, the B0-field induces a 
ring current that generates an additional magnetic field. The resulting anisotropy effect 
is stronger than those arising from double bonds. The strength of anisotropy is 
proportional to 1/r3, r being the distance from the anisotropy source. Thus, the δH-value 
of a proton-containing group can provide information about the spatial proximity of 
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another group having a known anisotropy effect. The ring-currents of larger π-systems 
produce such strong anisotropic effects in their proximity that they cover even more 
distance in space than NOE . 
 
Figure 2.2. Schematic representation of the magnetic anisotropic effect. Carbonyl 
group, carbon double bond, and benzene ring. Shielding effect is denoted with (+)-sign 
and deshielding with (–)-sign. 
 
                             Electric fields influence the electron densities of nuclei, and thus 
polarized charges (e.g. in amino, carbonyl, and nitro groups) affect their surroundings. 
The proton chemical shift can be strongly affected by hydrogen bonding. In a hydrogen 
bonded proton, the electron density is formally increased, but the electrostatic dipole 
field of the hydrogen bond produces a deshielding effect on the bonded hydrogen 
(Silverstein et al., 1963). 
 
                 2.5.2.2 Scalar Coupling  
                             In modern NMR spectroscopy, spectral assignment is largely based on 
the observed scalar couplings between NMR active nuclei in the molecules studied. 
Scalar spin couplings are mediated by bonding electrons, and thus the couplings are not 
only sensitive to the chemical structure, but also to bond conformations. The 
dependence of a vicinal coupling constant (3JH-H) on the dihedral angle φ between H–
C–C–H protons has been first theoretically formulated by Karplus with equation 2: 
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3JH-H = A + B cos φ + C cos 2φ        (2) 
A = 4.22, B = –0.5 and C = 4.5 
 
Experimentally, the Karplus equation (Eq. 2) has been found to predict φ-angles 
relatively well when the molecular fragment studied resembles ethane. However, it has 
been shown that the vicinal coupling constant (3JH-H) depends on electronegative 
substituents, solvent effects, bond-angles and bond-lengths. A number of variations for 
equation 2 exist in the literature in which the constants A, B, and C are readjusted, 
and/or trigonometric functions are added or altered to improve empirical correlation. 
The 2JC-H or 3JC-H values provide information similar to that given by the 3JH-H 
values about the dihedral angle, but the former couplings have been more difficult to 
obtain until recent developments in the NMR techniques. Matsumori et al. have shown 
that the determination of the stereochemistry for acyclic natural products is possible 
utilizing the 2 or 3JC-H values. Since the vicinal proton-carbon spin coupling constants 
(3JC-H) obey a Karplus-type equation, the conformations of C–C–H fragments can be 
evaluated. Also geminal 2JC-H values provide conformational information. Small 2JC-H 
values have been measured for the β-alkoxy CH2 group when the proton is in the gauche 
position with respect to the oxygen functionality of a neighbouring carbon atom, 
whereas for the anti conformation, large 2JC-H values have been measured (Derome, 
1987). 
 
        2.5.3 Fourier Transform Infrared (FT-IR) Spectroscopy  
                 Infrared spectroscopy is a technique used to identify various functional 
groups in unknown substances through the identification of different covalent bonds that 
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are present in the compound. By identifying the different covalent bonds that are present 
in a compound, one can establish the types of functional groups present. By comparing 
the absorptions seen in an experimental spectrum to the literature absorptions of various 
functional groups, one can determine a list of possible identities for the bonds present. 
Sometimes the absorptions are given in a chart, called a correlation chart. A simplified 
correlation table is given in Table 2.4 (Lambert et al., 1987). 
 
Table 2.4. A Simplified Correlation of Infrared Absorption with Organic Functional 
Groups.  
Functional Group Frequency (cm-1) Intensity  Assignment 
Alkanes Must have 
both peaks  
3000-2800 
1500-1450 
s 
s 
−C-H Stretch 
−C-H Bend 
Alkenes Must have 
both peaks  
3100-3000 
1675-1600 
m 
m 
=C-H Stretch 
C=C Stretch 
Alkynes Must have 
both peaks  
3300-3200 
2200-2100 
w 
w 
≡C-H Stretch 
C≡C Triple Bond Stretch 
Alcohols, Phenols 3600-3000 
(1300-1000) 
broad O-H Stretch 
(C-O Stretch) 
Aldehydes Must have 
all three peaks  
1750-1625 
2850-2800 
2750-2700 
s 
w 
w 
C=O Stretch 
C-H Stretch off C=O 
C-H Stretch off C=O 
Aromatic Rings (i.e. 
Benzene rings) Must 
have all three peaks  
3100-3000 
1600-1580 
1500-1450 
w 
m 
m 
=C-H Stretch 
C=C Stretch 
C=C Stretch 
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Table 2.4. (Continued). 
Functional Group Frequency (cm-1) Intensity  Assignment 
Ketones  1750-1625 s C=O Stretch 
Carboxylic Acids 
Must have both peaks  
3400-2400 
 
1730-1660 
(1320-1210) 
very broad 
 
s 
(s) 
H-bonded O-H Stretch 
across the entire range. 
C=O Stretch 
(C-O Stretch) 
Ethers  (1300-1000) (s) (C-O Stretch) 
Amines: Primary 
Must have both peaks  
3500-3200 
 
1640-1560 
m 
 
s 
N-H Stretch (two peaks in 
this range)  
N-H Bend 
Amines: Secondary 
Must have both peaks  
3500-3200 
 
1550-1450 
m 
 
s 
N-H Stretch (one peak in 
this range) 
N-H Bend 
Nitriles  2300-2200 m C-N Triple Bond Stretch 
Nitro Groups 
Must have both peaks  
1600-1500 
1400-1300 
(2 peaks < 200 
cm-1 apart) 
s 
s 
N=O Stretch 
N=O Stretch 
Amides 
Must have all three 
peaks  
3500-3100 
1670-1600 
1640-1550 
m 
s 
m 
N-H Stretch 
C=O Stretch 
N-H Bend 
Intensity Key: s= strong, m= medium, w= weak 
 
CHAPTER III 
EXPERIMENTAL 
 
3.1 General Techniques 
        3.1.1 Chemical Solvents 
                 The organic solvents were commercial grade and distilled prior to use for 
extraction and as eluents for thin layer and column chromatography. Reagent grade 
solvents were used for recrystallization. 
 
        3.1.2 Other Chemicals 
                 3.1.2.1. Merck’s silica gel 60 Art. 7734 (70-230 mesh ASTM) was used as 
adsorbent for normal column chromatography and 9385 (230-400 mesh ASTM) for 
flash chromatography. 
 
                 3.1.2.2. Merck’s silica gel 60 G Art. 7731 and 60 GF254 Art. 7730 were 
applied as adsorbent for preparative TLC. 
 
                 3.1.2.3. Merck’s TLC aluminum sheet, silica gel 60 F254 precoated 25 
sheets, 20x20 cm2, layer 0.2 mm was used to identify the identical fractions. 
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        3.1.3 Chromatography 
                 3.1.3.1 Thin Layer Chromatography (TLC) 
                             Techniques: One way, ascending. 
                             Adsorbent: Silica gel 60 F254 pre-coated on aluminum plate (Merck) 
                             size 2x5 cm2. 
                             Visualization:  1. Visualization under daylight. 
                                               2. Under ultraviolet light at 254 nm the compounds 
which contain unsaturated bonds especially conjugated systems are 
visible as quenching spots under UV light at 254 nm. 
                                               3. By staining TLC plates with anisaldehyde-sulfuric 
acid reagent (0.5% ethanolic solution of anisaldehyde with 5% 
sulfuric acid), the spot of organic compounds give specific color 
with this reagent after heating at 80-100oC for a few minutes. 
 
                 3.1.3.2 Column Chromatography  
                             Adsorbent: Unless indicated otherwise, silica gel with particle size 
less than 0.63 mm (E. Merck) was used throughout the 
experiments. 
                             Packing method: Slurry packing. 
                       Sample loading: The sample was dissolved in a small amount of a 
suitable organic solvent, mixed with a small quantity of silica gel 
60 with particle sizes 0.063-0.200 mm, air dried and added gently 
onto the top of column. 
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                        Elution: After loading of the sample, the column was eluted with a 
suitable solvent system using the gradient technique. 
 
                 3.1.3.3 Preparative Chromatography 
                             PLC plates were prepared as follows: A mixture of Merck’s silica 
gel 60 GF254 for preparative layer chromatography (200 g) in water (480 mL) was 
shaken thoroughly until the suspension was homogeneous. It was allowed to stand in 
a stopper flask for 1-2 hr before being spread onto eight 20 x 20 cm2 plates. The plates 
were left to dry in still air for 24 hr and then in an oven at 100oC for 1 hr. Bands were 
detected by viewing under a UV lamp at 254 and 365 nm. 
 
3.2 Spectroscopy 
        3.2.1 UV-Visible Spectrometer 
                 UV-visible absorbance was measured on a Hewlett Packard 8452A diode 
array UV-VIS spectrophotometer. 
 
        3.2.2 FT-IR Spectrophotometer  
                 IR spectra were recorded on a Perkin-Elmer FT-IR 2000 
spectrophotometer. Spectra of solid samples were recorded as potassium bromide 
(KBr) pellets.  
 
        3.2.3 NMR Spectrometer 
                 The 1H-NMR and 13C-NMR spectra were recorded at 500 MHz and 125 
MHz, respectively on a Bruker DMX500 NMR spectrophotometer in deuterated 
 52
pyridine (C6D5N). The chemical shifts were recorded in parts per million with 
reference to the solvent signals.  
                 The numbers of hydrogen atoms attached to each carbon atom were 
obtained from J-modulated spin-echo experiments. 2-D NMR spectroscopy was 
performed with standard COSY (1H-1H correlation), HSQC (13C-1H correlation) and 
HMBC (long range carbon-proton correlation) pulse sequences. 
 
3.3 Source of Plant Materials 
        Fresh aerial parts of C. nutans were collected from Bangkok, Chanthaburi and 
Nakhon Pathom provinces, Thailand. The specimens were authenticated by the 
Botanical section, Medicinal Plant Research Institute, Department of Medical 
Sciences, Ministry of Public Health. The leaves were separated from the stems, 
washed thoroughly and dried in an oven at 50οC. The dried samples were ground to 
powder. 
 
3.4 Extraction  
        The dried powdered leaves (4900 g) were extracted (4 x 1225 g) consecutively 
with hexane and chloroform in a soxhlet extraction apparatus at reflux (3 x 4 liters for 
each solvent) The figure below shows the soxhlet extraction apparatus in the natural 
product chemistry section, Medicinal Plant Research Institute, Department of Medical 
Sciences, Ministry of Public Health. 
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Figure 3.1. Soxhlet extraction apparatus. 
 
        The extracted solutions were then filtered through filter paper, the filtrates were 
concentrated to remove solvent by evaporation under reduced pressure on a rotary 
evaporator giving 144.5 g (2.95% yield based on dry weight) of hexane crude extract 
as dark green slush, 90.5 g of chloroform crude extract (1.85% yield based on dry 
weight). The extraction sequence was as shown in Scheme 3.1.  
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Scheme 3.1. Extraction of the leaves of C. nut
 
3.5 Isolation  
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separated by monitoring with TLC in order to combine the fractions which had the 
same compounds. The isolation sequence was as shown in Scheme 3.2.  
 
 
                                                                            Column Chromatography, Silica gel 
                                                                            -hexane: ethyl acetate 1:1 
                                                                            -ethyl acetate 
                                                                            -chloroform 
                                                                            -chloroform: ethanol 1:1 
                                                                            -ethanol 
 
 
            fraction I              fraction II                                   fract n III         fraction IV 
Chloroform Extract 
 
Scheme 3.2. Isolation of chloroform crude extract. 
 
        A portion of Fraction I (1.0017g) was further separated 
chromatography (hexane–ethyl acetate 7:3) to afford five fr
0.0406 g, C 0.0791 g, D 0.0697 g and E 0.1469 g). Fraction 
purified by preparative thin-layer chromatography using the 
to give crude compound 24 (0.0136 g), which was recry
(0.0058 g). The Isolation sequence of compound 24 was as sh
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same developing solvent 
stallized from methanol 
own in Scheme 3.3.  
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                                                                            Preparative thin-layer chromatography  
                                                                           -hexane: ethyl acetate 7:3            
 
 
 
                 fraction A          fraction B         fraction C            fraction D         fraction E 
                                                       
                                                     -Preparative thin-layer chromatography 
                                                     -hexane: ethyl acetate 7:3 
fraction I 
 
                                         compound 24 
                                                                                            
Scheme 3.3. Isolation of compound 24 from chloroform crude extract. 
 
        Faction III (30.51g) was chromatographed on a silica gel 60 column (855 g) and 
eluted successively with chloroform, chloroform containing increasing amounts of 
ethanol in gradient. Every fraction was collected, concentrated to a small volume and 
then monitored by TLC using the same solvent system as mentioned above in order to 
combine the fractions which had the same compounds. Five fractions (A' 1.39 g, B' 
0.80 g, C' 0.49 g, D' 6.13 g and E' 2.55 g) were obtained. 
      Fraction A' (1.39 g) was purified by PLC using chloroform–methanol (9:1) as the 
developing solvent to give crude compound 25 (0.3530 g). The crude compound was 
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further purified by preparative thin-layer chromatography using hexane–ethyl acetate 
(7:3) as the solvent system to provide pure compound 25 (0.0285 g). The isolation 
sequence of compound 25 was as shown in Scheme 3.4. 
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fraction III  
 
                                                                            Column Chromatography, Silica gel 
                                                                          -chloroform: ethanol 10:0-0:10 
 
 
 
fraction B'        fraction A'                                      fraction C'               fraction D'         fraction E' 
 
                                                Preparative thin-layer chromatography                        
                                              -chloroform: ethanol 9:1 
 
compound 26  
 
Scheme 3.5. Isolation of compound 26 from chloroform crude extract. 
 
3.6 Purification and Characterization of the Isolated Compounds 
        3.6.1 Purification and Characterization of Compound 24 
                 Compound 24 was obtained from the first column chromatography, 
fraction I 1.0017 g of chloroform crude extract. Repetitive silica gel column 
chromatography as indicated in Scheme 3.3. The solvent was removed by rotary 
evaporator and the compound was recrystallized from methanol several times to 
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provide 0.0058 g (0.21% yield based on chloroform crude extract and 0.0039% yield 
from starting material). This compound is soluble in chloroform and dichloromethane. 
        UV (CHCl3) λ max (CHCl3) 242, 315, 438, 520, 600, and 670 nm (Figure A.1). 
        FT-IR spectrum νmax (KBr) 3429, 2925, 2852, 1721, 1637, 1300, 1277, and 1132 
cm-1 (Table 4.2 p63 and Figure A.2). 
        1H NMR δ ppm, in pyridine-d5, 1.74 (3H, d, J = 6.3 Hz, 181-H),1.81 (3H, t, J = 
7.55 Hz, 82-H), 3.45 (3H, s, 21-H), 3.72 (3H, s, 121-H), 3.85 (3H, s, 134-H), 4.19 (2H, 
q, J = 7.6 Hz, 81-H), 4.67 (1H, dq, J = 7.45Hz, 18-H), 5.23 (1H, m, 17-H), 6.21 (1H, 
dd, J = 12.6 Hz, 32-H), 6.54 (1H, dd, J = 17.85 Hz, 32-H), 8.92 (1H, s, 20-H), 10.16 
(1H, s, 10-H), 11.01 (1H, s, 5-H), 11.48 (1H, s, 71-H) (Table 4.3 p65 and Figure A.3).  
        13C NMR δ ppm, in pyridine-d5, 194.9 (131-C), 188.0 (71-C), 175.6 (19-C), 91.3 
(132-C), 174.0 (173-C), 144.0 (1-C), 137.5 (3-C), 138.1 (11-C), 133.5 (2-C), 129.5 
(31-C), 123.0 (32-C), 108.2 (10-C), 102.6 (5-C), 95.1 (20-C), 53.6 (134-C), 51.5 (17-
C), 51.1 (18-C), 32.7 (172-C), 32.4 (171-C), 23.3 (181-C), 19.9 (82-C), 19.6 (81-C), 
12.5 (121-C), 12.4 (21-C) (Table 4.4 p66 and Figure A.4). 
 
        3.6.2 Purification and Characterization of Compound 25 
                 Compound 25 was obtained from fraction III 30.5 g of first column 
chromatography of chloroform crude extract after repeated column chromatography 
using silica gel as an adsorbent, and appropriate solvent systems as indicated in 
Scheme 3.4. The final fraction (fraction A' 1.39 g) was chromatographed by 
preparative thin-layer chromatography to obtain 0.0285 g (0.031% yield based on 
chloroform crude extract and 0.00058% yield from starting material). This compound 
is soluble in chloroform and dichloromethane 
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        UV (CHCl3) λmax 260, 360, 420, 545, 640, and 700 nm (Figure A.9). 
        FT-IR spectrum νmax (KBr) 3430, 2925, 2856, 1734, 1705, and 1620 cm-1 (Table 
4.9 p75 and Figure A.10). 
        1H NMR δ ppm, in pyridine-d5, 1.69 (3H, t, J = 7.7 Hz, 82-H), 1.83 (3H, d, J = 
7.4 Hz, 181-H), 2.78, 3.02 (2H, m, 172-H), 2.33, 2.85 (2H, m, 171-H), 3.17 (3H, s, 71-
H), 3.32 (3H, s, 21-H), 3.71 (2H, q, J = 7.7 Hz, 81-H), 3.84 (3H, s, 121-H), 4.67 (1H, 
q, J = 7.3 Hz, 18-H), 5.46 (1H, m, 17-H), 6.20 (1H, dd, J = 11.6, 1.1 Hz, 32-H), 6.41 
(1H, dd, J = 17.8, 1.1 Hz, 32-H), 8.10 (1H, dd, J = 17.8 , 11.5 Hz, 31-H), 8.92 (1H, s, 
20-H), 9.66 (1H, s, 5-H), 9.89 (1H, s, 10-H) (Table 4.10 p77 and Figure A.11). 
        13C NMR δ ppm, in pyridine-d5, 178.3 (16-C), 175.6 (19-C), 173.6 (173-C), 
160.1 (131-C), 157.2 (6-C), 151.4 (9-C), 147.0 (8-C), 145.0 (1-C), 140.8 (12-C), 140.0 
(14-C), 138.0 (4-C), 137.9 (3-C), 137.5 (7-C), 133.0 (2-C), 132.5 (11-C), 129.3 (31-
C), 123.0 (32-C), 112.7 (13-C), 108.9 (10-C), 104.0 (5-C), 95.1 (20-C), 94.0 (15-C), 
56.0 (17-C), 51.1 (18-C), 33.6 (172-C), 32.4 (171-C), 23.3 (181-C), 20.0 (81-C), 18.1 
(82-C), 12.7 (121-C), 12.4 (21-C), 11.4 (71-C) (Table 4.11 p78 and Figure A.12). 
 
        3.6.3 Purification and Characterization of Compound 26  
                 Compound 26 was obtained from fraction III of the first column 
chromatography of chloroform crude extract was further chromatographed over silica 
gel, using a combination of eluting solvents as indicated in Scheme 3.5. The final 
fraction (fraction B' 0.8 g) was chromatographed by preparative thin-layer 
chromatography obtain to 0.0136 g (0.015% yield based on chloroform crude extract 
and 0.00028% yield from starting material). This compound is soluble in chloroform 
and dichloromethane 
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      UV (CHCl3) λmax 250, 280, 410, and 665 nm (Figure A15). 
      FT-IR spectrum νmax (KBr) 3429, 2925, 2852, 1721, 1637, 1300, 1277, 1132, and 
1095 cm-1 (Table 4.14 p84 and Figure A.16). 
      1H NMR δ ppm, in pyridine-d5, 1.71 (3H,t, J = 7.7 Hz, 82-H), 1.86 (3H, d, J = 7.2 
Hz, 181-H), 2.70, 3.10 (2H, m, 171-H), 2.79, 2.99 (2H, m, 172-H), 3.26 (3H, s, 71-H), 
3.38 (3H, s, 21-H), 3.69 (3H, s, 121-H), 3.75 (2H, q, J = 7.6 Hz, 81-H), 3.93 (3H, s, 
134-H), 4.59 (1H, m, 17-H), 4.66 (1H, dq, J = 7.3, 2.0 Hz, 18-H), 6.21 (1H, dd, J = 
11.6 Hz, 32-H), 6.40 (2H, dd, J = 17.8 Hz, 32-H), 6.90 (1H, s, 132-H), 8.22 (1H, dd, J 
= 17.8, 11.5 Hz, 31-H), 8.86 (1H, s, 20-H), 9.73 (1H, s, 5-H), 9.90 (1H, s, 10-H) 
(Table 4.15 p86 and Figure A.17). 
      13C NMR δ ppm, in pyridine-d5, 190.3 (131-C), 170.8 (133-C), 163.0 (16-C), 156.4 
(6-C), 151.9 (9-C), 150.5 (14-C), 146.2 (8-C), 142.7 (1-C), 138.8 (11-C), 137.3 (7-C), 
136.8 (3-C), 133.0 (2-C), 130.1 (13-C), 129.9 (31-C), 129.7 (12-C), 123.0 (32-C), 
106.9 (15-C), 105.5 (10-C), 90.3 (5-C), 94.6 (20-C), 65.9 (132-C), 53.2 (134-C), 52.5 
(17-C), 50.8 (18-C), 32.9 (172-C), 31.2 (171-C), 23.6 (181-C), 20.0 (81-C), 18.0 (82-C), 
12.5 (21-C), 12.3 (121-C), 11.6 (71-C) (Table 4.16 p88 and Figure A.18). 
CHAPTER IV 
RESULTS AND DISCUSSION 
 
4.1 Isolation and Separation of Chloroform Crude Extract of 
       Clinacanthus nutans 
       Repeated chromatographic separations of chloroform crude extract led to 
isolation of several pure compounds. Structure determination of three isolated 
compounds were achieved by spectroscopic method. 
 
Table 4.1. The Results of Separation of Chloroform Crude Extract by Column 
Chromatography. 
Compounds Physical appearance Wt. % Wt. by Wt 
24 
25 
26 
Green amorphous solid 
Brown amorphous solid 
Deep-green amorphous  
solid 
        0.0058 g 
        0.0285 g 
        0.0136 g 
        0.0039 
        0.00058 
        0.00028 
 
4.2 Structure Elucidation of Isolated Compounds from the Leaves of 
       Clinacanthus nutans 
       4.2.1 Structure Elucidation of Compound 24 
                The characteristic dark green color and the UV spectrum (Figure A.1) of  
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compound 24 suggested that compound 24 is a chlorophyll derivative compound 
(Watanabe et al.,1993). 
                The IR spectrum of compound 24 was shown in Figure A.2 and the 
absorption peaks were assigned as shown in Table 4.2. 
 
Table 4.2. IR Absorption Band Assignment of Compound 24. 
Wave number (cm-1) Intensity Tentative Assignment 
3429 
2925, 2852 
1721, 1637 
1300, 1277, 1132 
s 
m 
m 
m 
N-H Stretch 
C-H Stretch 
C=O Stretch 
             C-H Bend 
 
      Information from 1H-NMR and 13C-NMR spectra showed the necessary 
diagnostic peaks to be identified as a pheophytin b derivative with a hydroxyl group 
on C-132. The 3H-21 and 3H-121 resonances occurred as sharp singlets at δ 3.45 and 
3.72, respectively. H-5, H-10, and H-20 were found as sharp singlets at δ 11.01, 
10.16, and 8.92, respectively. A vinyl group was present at C-3 as indicated by the H-
31 doublet of doublets at δ 8.18 (J = 15.19, 11.39 Hz) and the H-32 (E) and the H-32 
(Z) doublet of doublets at δ 6.54 (J = 15.19, 2.28 Hz) and 6.21 (J = 11.39, 2.28), 
respectively. An ethyl group was found to occur at C-8. The 2H-81 resonances 
appeared as a quartet at δ 4.19 (J = 7.65 Hz) and 3H-82 occurred as a triplet at δ 1.81 
(J = 4.65 Hz). Similarly, as with pheophytin b, a five membered carbocyclic ring was 
presented at position 13. A keto group was found at C-131 as indicated by the fully 
substituted carbon resonance at δ 194.9. The C-132 resonances occurred at δ 91.3 as 
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with pheophytin b and a methyl ester was also presented at C-133. This was indicated 
by C-133 occurring as a fully substituted carbon resonance at δ 174.0 and the C-134 
methyl carbon resonance being presented at δ 53.6. The H-134 resonance was found 
as a sharp singlet at δ 3.85. The characteristic signal of phytyl ester appeared at δ 5.41 
(H-p2) and 4.72 (H-p1), the C-p1 and C-p2, resonances appeared at δ 61.8 and 121.3. 
      Compound 24 exhibited the 1H-NMR and 13C-NMR chemical shifts identical to 
132-hydroxy-(132-S) pheophytin b (Nakatani et al., 1981). A comparison of the 1H-
NMR and 13C-NMR chemical shifts of compound 24, 132-hydroxy-(132-S) 
pheophytin b and 132-hydroxy-(132-S) pheophytin a (Matsuo et al., 1996) are shown 
in Tables 4.3 and 4.4. These data indicated that compound 24 is 132-hydroxy-(132-S) 
pheophytin b (Figure 4.1).  
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Figure 4.1. Structure of compound 24. 
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Table 4.3. The 1H-NMR Chemical Shifts of Compound 24#, 132-Hydroxyl-(132-S) 
Pheophytin b& and 132-Hydroxyl-(132-S) Pheophytin a* (Excluding Phytyl Moiety). 
Chemical Shifts (ppm), Coupling Constant (Hz)  
Proton 
Position 
Compound 24  132-Hydroxyl-
(132-S) Pheophytin 
b 
132-Hydroxyl-
(132-S) Pheophytin 
a 
  21
  31 
  32 (E) 
  32 (Z) 
  5 
  71
  81
  82
10 
121
132-OH 
134-OMe 
17 
171
171
172
172
  3.45 (s) 
  8.18 (dd, J = 11.65,10.9)  
  6.54 (dd, J = 17.8, 2.5) 
  6.21 (dd, J = 12.6, 2.5) 
11.01 (s) 
11.48 (s) 
  4.19 (q, J = 7.65) 
  1.81 (t, J = 7.55) 
10.16 (s) 
  3.72 (s) 
  6.52 
  3.85 (s) 
  5.23 (t, J = 6.4) 
  2.88 
  2.67 
  2.81 
  2.46 
                3.40  
                8.04 
                6.32  
                6.32  
              10.51  
              11.21  
                 
                 
                9.79  
                3.63  
                5.59 
                3.75 
                4.19 
 
          3.43 (s) 
          8.01 (dd) 
          6.30 (dd) 
          6.20 (dd) 
          9.47 (s) 
          3.25 (s) 
          3.70 (q) 
          1.70 (t) 
          9.62 (s) 
          3.74 (s) 
          5.53 
          3.62 (s) 
          4.17 (ddd) 
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Table 4.3. (Continued). 
Chemical Shifts (ppm), Coupling Constant (Hz)  
Proton 
Position 
Compound 24  132-Hydroxyl-
(132-S) Pheophytin 
b 
132-Hydroxyl-
(132-S) Pheophytin 
a 
18 
181
20 
NH 
  4.67 (q, J = 7.3) 
  1.74 (t, J = 6.95) 
  8.92 (s) 
  0.66 (br, s), -1.33 (br, s) 
                4.58  
                 
                8.61 
          4.50 (dq) 
          1.61 (d) 
          8.65 (s) 
                     
#500 MHz 1H, pyridine d5 
&250 MHz 1H, CDCl3
* 400 MHz 1H, CDCl3
 
Table 4.4. 13C-NMR Chemical Shifts of Compound 24# and 132-Hydroxyl-(132-S)-
Pheophytin a* (Excluding Phytyl Moiety). 
Carbon Position Compound 24 
(ppm) 
132-Hydroxyl-(132-S)-
Pheophytin a    (ppm) 
                 1 
                 2 
                 21
                 3 
                 31
                 32
                 4 
                 144.0 
                 133.5 
                   12.4 
                 137.5 
                 129.5 
                 123.0 
                 137.4 
                 142.8 
                 131.8 
                   12.1 
                 136.6 
                 129.1 
                 122.9 
                 136.3 
 
 67
Table 4.4. (Continued). 
Carbon Position Compound 24 
(ppm) 
132-Hydroxyl-(132-S)-
Pheophytin a    (ppm) 
                 5 
                 6 
                 7 
                 71
                 8 
                 81
                 82
                 9 
               10 
               11 
               12 
               121
               13 
               131
               132
               133
               134
               14 
               15 
               16 
               17 
                 102.6 
                 160.2 
                 138.9 
                 188.0 
                 148.3 
                   19.6 
                   19.9 
                 151.8 
                 108.2 
                 138.1 
                 138.8 
                   12.5 
                 128.9 
                 194.9 
                   91.3 
                 174.0 
                   53.6 
                 151.1 
                   91.3 
                 166.8 
                   51.5 
                   98.0 
                 155.4 
                 136.2 
                   11.3 
                 145.8 
                   19.5 
                   17.4 
                 151.1 
                 104.3 
                 137.8 
                 129.4 
                   12.3 
                 127.0 
                 192.0 
                   89.0 
                 172.8 
                   53.4 
                 149.8 
                 107.7 
                 162.5 
                   51.8 
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Table 4.4. (Continued). 
Carbon Position Compound 24 
(ppm) 
132-Hydroxyl-(132-S)-
Pheophytin a    (ppm) 
                 171
                 172
                 173
                 18 
                 181
                 19 
                 20 
                   32.4 
                   32.7 
                 173.5 
                   51.1 
                   23.3 
                 175.6 
                   95.1 
                   31.1 
                   31.6 
                 173.6 
                   50.3 
                   22.7 
                 172.4 
                   93.6 
# 125 MHz 13C, pyridine d5 
* 100 MHz 13C, CDCl3
 
      Further studies of the structure of compound 24 were done by analysis of the 
COSY, HSQC, HMBC, and NOESY correlations (see also Tables 4.5-4.8). 
      The COSY spectrum (Figure A.5) indicated that one proton doublet of doublets at 
δ 8.18 (H-31) coupled to one proton doublet of doublets at δ 6.54 (H-32 E), and one 
proton doublet of doublets at 6.21 (H-32 Z). The signal at δ 5.41 (H-P2) correlated 
only with the signal at δ 4.72 (H-P1). The signal of one proton at 4.67 (H-18) showed 
a cross peak with a signal at δ 1.74 (H-181). Study of the COSY (H-H) spectrum of 
compound 24 led to the complete assignment of 1H and 13C shift signals as shown in 
Table 4.5.  
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Table 4.5. Observed Correlation in the COSY (H-H) Spectrum of Compound 24 (in 
Pyridine d5).  
δ 1H-NMR (Position) COSY (Coupled Hydrogen) 
                         8.18 (H-31) 
                         4.19 (H-81) 
                         5.23 (H-17) 
                         2.88, 2.67 (H-171) 
                         4.67 (H-18) 
                         5.41 (H-P2) 
             6.54 (H-32 E), 6.21 (H-32 Z) 
                         1.81 (H-82) 
                         2.88, 2.67 (H-171) 
                         2.81, 2.46 (H-172) 
                         1.74 (H-181) 
                         4.72 (H-P1) 
 
      One Bond Correlation (HSQC) data revealed that the proton at δ 10.16 (H-10) was 
attached to the carbon at δ 108.2 (C-10), the proton at δ 11.01 (H-5) was attached to 
the carbon at δ 102.6 (C-5), the proton at δ 8.92 (H-20) was attached to the carbon at δ 
95.1 (C-20), the proton at δ 8.18 (H-31) was attached to the carbon at δ 129.5 (C-31), 
the protons at δ 6.54 (H-32 E) and 6.21 (H-32 Z) were attached to the carbon at δ 
123.0 (C-32), the proton at δ 5.23 (H-17) was joined with the carbon at δ 51.5 (C-17), 
the proton at δ 4.67 (H-18) was joined with the carbon at δ 51.1 (C-18), the proton at 
δ 3.72 (H-121) was joined with the carbon at δ 12.5 (C-121), the proton at δ 4.19 (H-
81) was joined with the carbon at δ 19.6 (C-81), and the proton at δ 3.45 (H-21) was 
joined with the carbon at δ 12.4 (C-21). The protons attached to the carbons in 
compound 24 were assigned by the HSQC spectrum as shown in Figure A.6 and 
Table. 4.6. 
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Table 4.6. Observed Correlations in HSQC Vicinal (C-H) Spectrum of Compound 24 
(in Pyridine d5). 
δ 1H-NMR (Position) HSQC (Attached Carbon) 
                         3.45 (H-21) 
                         8.18 (H-31) 
                         6.54 (H-32 E) 
                         6.21 (H-32 Z) 
                       11.01 (H-5) 
                       11.48 (H-71) 
                         4.19 (H-81) 
                         1.81 (H-82) 
                       10.16 (H-10) 
                         3.72 (H-121) 
                         5.23 (H-17) 
                         4.67 (H-18) 
                         1.74 (H-181) 
                         8.92 (H-20) 
                       12.4 (C-21) 
                       129.5 (C-31) 
                       123.0 (C-32) 
                       123.0 (C-32) 
                       102.6 (C-5) 
                       188.0 (C-71) 
                         19.6 (C-81) 
                         19.9 (C-82) 
                       108.2 (C-10) 
                         12.5 (C-121) 
                         51.5 (C-17) 
                         51.1 (C-18) 
                         23.3 (C-181) 
                         95.1 (C-20) 
 
      In the H-C long range coupling spectrum obtained by HMBC, the proton at δ 6.45 
(H-32 E) showed cross peaks with the carbons at 129.5 (C-31) and 137.5 (C-3), the 
proton at δ 6.21 (H-32 Z) showed a cross peak with the carbon at 137.5 (C-3), the 
proton at δ 1.74 (H-181) showed cross peaks with the carbons at 175.6 (C-19), 51.1 
(C-18), and 51.5 (C-17), the proton at δ 5.23 (H-17) showed a cross peak with the 
carbon at 23.3 (C-181), the proton at δ 3.45 (H-21) showed cross peaks with the 
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carbons at 137.5 (C-3) and 144.0 (C-1), and the proton at δ 8.92 (H-20) showed a 
cross peak with the carbon at 133.5 (C-2) (Figure A.7 and Table 4.7). 
 
1
2
3
N
4
5
6
7
8
NH
P11
P4
11
8
3
14
N
12
10
17
18
19
20
HN
21 22
2324
18
1
3 CHO
P7
1
P10
P8
1
2
O
2
17
HO
2
1
13
9
O
1
1
12
13
P5
15
16
17
O
2
MeO
P2
O
7
P6
1
13
8
P1
P3
17
P9
P12
3
2
1
P7
1
P3
1
P16
P15
P14
P13
P15
1P11
13
3
4
1
13
 
 
Figure 4.2. The HMBC correlations of compound 24. 
 
Table 4.7. Observed Long Range C-H Correlations in the HMBC of Compound 24 
(in Pyridine d5).  
δ 1H-NMR (Position) HMBC (Correlation Carbon) 
                         3.45 (H-21) 
 
                         6.45 (H-32 E) 
                         6.21 (H-32 Z) 
144.0 (C-1), 133.5 (C-2), 137.5 (C-3), 
138.1 
129.5 (C-31), 137.5(C-3) 
137.5 (C-3) 
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Table 4.7. (Continued). 
δ 1H-NMR (Position) HMBC (Correlation Carbon) 
                         11.01 (H-5) 
                           4.19 (H-81) 
                           1.81 (H-82) 
                         10.16 (H-10) 
                           3.72 (H-121) 
                           3.85 (H-134) 
                           5.23 (H-17) 
                           4.67 (H-18) 
                           1.74 (H-181) 
  
                           8.92 (H-20) 
137.5 (C-3) 
19.9 (C-82) 
19.63 (C-81), 138.1 (C-11) 
138.1 (C-11) 
138.9 (C-12), 138.1 (C-11) 
174.0 (C-133) 
23.3 (C-181) 
23.3 (C-181), 32.4 (C-171), 32.7 (C-172) 
175.6 (C-19), 51.0 (C-18), 51.4 (C-17), 
53.6 (C-134) 
133.5 (C-2), 144.0 (C-1), 51.4 (C-17), 
51.0 (C-18) 
 
      The NOESY correlation spectrum showed the appearance of coupling between the 
proton at δ 1.81 (H-82) ppm and the proton at 4.19 (H-81) ppm, coupling between the 
proton at δ 5.23 (H-17) ppm and the proton at δ 3.85 (H-134) ppm, coupling between 
the proton at δ 11.48 (H-71) ppm and the proton at δ 1.81 (H-82) ppm, 4.19 (H-81) 
ppm, coupling between the proton at δ 11.01 (H-5) ppm and the protons at δ 6.54 (H-
32 E) ppm, and 8.18 (H-31), coupling between the proton at δ 11.01 (H-5) ppm and the 
protons at δ 6.54 (H-32 E) ppm, and 8.18 (H-31), The 3D structure of compound 24 
could be drawn as shown in Figure 4.3 with the use of a molecular model. The NOE 
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effects obtained from the NOESY spectra could be seen as indicated in Figure A.8, 
Figure 4.3, and Table 4.8 which are in good agreement with the proposed structure. 
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Figure 4.3. The NOESY correlations of compound 24. 
 
Table 4.8. Observed NOE Correlation of Compound 24 (in Pyridine d5). 
δ 1H-NMR (Position) NOESY (Cross Peaks) 
                         8.18 (H-31) 
                         6.54 (H-32 E) 
                       11.01 (H-5) 
                       11.48 (H-71) 
                         1.81 (H-82) 
             6.54 (H-32 E), 6.21 (H-32 Z) 
             3.45 (H-21), 11.48 (H-71) 
             6.54 (H-32 E), 8.18 (H-31) 
             1.81 (H-82), 4.19 (H-81) 
             4.19 (H-81) 
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Table 4.8. (Continued). 
δ 1H-NMR (Position) NOESY (Cross Peaks) 
                       10.16 (H-10) 
                         5.23 (H-17) 
                         1.74 (H-181) 
                         8.92 (H-20) 
             1.81 (H-82), 4.19 (H-81) 
             3.85 (H-134) 
             3.85 (H-134) 
             3.45 (H-21), 3.85 (H-134)  
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       4.2.2 Structure Elucidation of Compound 25 
                Compound 25 was obtained as a grayish green solid. The UV spectrum 
(Figure A.9) showed absorptions of a chlorophyll derivative compound (Watanabe et 
al., 1993). 
                The IR spectrum of compound 25 is shown in Figure A.10 and the 
absorption peaks were assigned as shown in Table 4.9. 
 
Table 4.9. IR Absorption Band Assignment of Compound 25. 
Wave Number (cm-1) Intensity Tentative Assignment 
3430 
2925, 2856 
1734, 1705, 1620 
s 
m 
m 
             N-H Stretch 
             C-H Stretch 
             C=O Stretch 
 
      The 1H-NMR spectrum (Figure A.11) of compound 25 showed the presence of the 
following signals: three olefinic methyl groups at δ 3.32 (s), 3.17 (s), and 3.84 (s); one 
vinyl group at δ 8.10 (dd, J = 11.5, 17.8 Hz); one ethyl group at δ 3.71 (q, J = 7.4 Hz); 
three olefinic protons at δ 9.66 (s), 9.89 (s), and 8.84 (s); two aliphatic protons at δ 
5.46 (m), 4.67 (q, J =7.3 Hz), and one secondary methyl group at δ 1.74 (d, J = 7.4 
Hz).; a –CH2CH2C (=O)– group and a phytyl group. The 13C-NMR spectrum of 
compound 25 displayed three carbonyl carbon signals at δ 160.1, 165.0, and 173.6. 
The 1H-NMR and 13C-NMR spectra of compound 25 closely matched that of purpurin 
18 (Chan et al., 1999). The difference of the 1H-NMR and 13C-NMR spectra between 
compound 25 and purpurin 18, a methyl ester signal at δH 3.77 (s) and δC 51.63 (q) in 
purpurin 18 were replaced by the characteristic signals of phytyl in compound 25 at 
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δH: 5.46 (H-P2) and 4.76 (H-P1); δC: 117.8 (C-P2), 61.4 (C-P1) and 142.7 (C-P3). 
Thus, compound 25 was the phytyl ester of purpurin 18.  
      From the above results, compound 25 exhibited the 1H-NMR and 13C-NMR 
chemical shifts identical to purpurin 18 phytyl ester (Chan et al., 1999). A comparison 
of the 1H-NMR and 13C-NMR chemical shifts of compound 25, purpurin 18 phytyl 
ester and purpurin 18 (Watanabe et al., 1993). are shown in Tables 4.10 and 4.11. 
These data indicated that compound 25 is as purpurin 18 phytyl ester (Figure 4.4).  
 
 
 
Figure 4.4. Structure of compound 25. 
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Table 4.10. The 1H-NMR Chemical Shifts of Compound 25#, purpurin 18 phylyl 
ester*, and Purpurin 18* (Excluding Phytyl Moiety). 
Chemical Shifts (ppm), Coupling Constant (Hz) Proton 
Position Compound 25   
 
Purpurin 18 phylyl Ester Purpurin 18  
  21
  31
  32 (E) 
  32 (Z) 
  5 
  71
  81
  82
10 
121
17 
171
171
172
172
18 
181
20 
3.32 (s) 
8.10 (dd, J = 17.8, 11.5) 
6.41 (dd, J = 17.8, 1.1) 
6.20 (dd, J = 11.6, 1.1) 
9.66 (s) 
3.17 (s) 
3.71 (q, J = 7.7) 
1.69 (t, J = 7.7) 
9.89 (s) 
3.84 (s) 
5.46 (m) 
2.33 (m) 
2.85 (m) 
2.78 (m) 
3.02 (m) 
4.67 (q, J = 7.3) 
1.74 (d, J = 7.4) 
8.84 (s) 
3.34 (s) 
7.87 (dd, J = 17.6, 11.6) 
6.28 (d, J = 17.6) 
6.18 (d, J = 11.6) 
9.28 (s) 
3.10 (s) 
3.55 (q, J = 7.4) 
1.61 (t, J =7.4) 
9.43 (s) 
3.72 (s) 
5.20 (m) 
2.04 (m) 
2.46 (m) 
2.46 (m) 
2.74 (m) 
4.40 (m) 
1.74 (d, J =7.2) 
8.56 (s) 
    3.34 (s) 
    7.88 (dd) 
    6.29 (dd) 
    6.19 (dd) 
    9.37 (s) 
    3.16 (s) 
    3.64 (q) 
    1.66 (t) 
    9.60 (s) 
    3.78 (s) 
    5.19 (dd) 
    1.99 (m) 
    2.5 (m) 
    2.5 (m) 
    2.79 (m) 
    4.39 (q) 
    1.74 (d) 
    8.57 (s) 
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Table 4.10. (Continued). 
Chemical Shifts (ppm), Coupling Constant (Hz) Proton 
Position Compound 25   
 
Purpurin 18 phylyl Ester Purpurin 18 
NH 
NH 
0.11 (br s) 
0.38 (br s) 
   0.11 (br. s) 
  -0.16 (br. s) 
0.23 (br. s) 
-0.07 (br. s) 
# 500 MHz 1H, pyridine d5 
*400 MHz 1H, CDCl3
 
Table 4.11. 13C-NMR Chemical Shifts of Compound 25# and Known Purpurin 18* 
(Excluding Phytyl Moiety). 
Carbon Position Compound 25 (ppm) Purpurin 18 (ppm) 
                   1 
                   2 
                   21
                   3 
                   31
                   32
                   4 
                   5 
                   6 
                   7 
                   71
                   8 
                145.0 
                133.0 
                  12.4 
                137.9 
                129.3 
                123.0 
                138.0 
                104.0 
                157.2 
                137.5 
                  11.4 
                147.0 
                144.1 
                131.8 
                  11.9               
                137.7 
                129.9 
                128.3 
                136.6                 
                103.0 
                156.1 
                136.6 
                  10.9 
                 145.9 
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Table 4.11. (Continued). 
Carbon Position Compound 25 (ppm) Purpurin 18 (ppm) 
                   81
                   82
                   9 
                 10 
                 11 
                 12 
                 121
                 13 
                 131
                 132
                 14 
                 15 
                 16 
                 17 
                 171
                 172
                 173
                 18 
                 181
                 19 
                 20 
                  20.0 
                  18.1 
                151.4 
                108.9 
                132.5 
                140.8 
                  12.7 
                112.7 
                160.1 
                165.0 
                140.0 
                  94.0 
                178.3 
                  56.0 
                  32.4 
                  33.6 
                173.6 
                  49.8 
                  24.4 
                177.7 
                  96.2 
                  19.3            
                  17.3            
                149.9 
                107.5 
                139.1 
                131.5 
                  12.2 
                111.4 
                177.2 
                176.4              
                164.1 
                  92.5 
                159.3 
                  55.0 
                  31.0       
                  32.2         
                177.5         
                  49.2 
                  23.8          
                176.6 
                  95.0 
& 125 MHz 13C, pyridine d5, # 100 MHz 13C, CDCl3
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      Further studies of the structure were done by analysis of HSQC and HMBC 
correlations (see also Tables 4.12 and 4.13). 
      One Bond Correlation (HSQC) data revealed that the proton at δ 9.89 (H-10) was 
attached to the carbon at δ 108.9 (C-10), the proton at δ 9.66 (H-5) was attached to the 
carbon at δ 104.0 (C-5), the proton at δ 8.84 (H-20) was attached to the carbon at δ 
96.2 (C-20), the proton at δ 8.10 (H-31) was attached to the carbon at δ 129.3 (C-31), 
the protons at δ 6.41 (H-32 E) and 6.20 (H-32 E) were attached to the carbon at δ 
123.0 (C-32), the proton at δ 5.46 (H-17) was joined with the carbon at δ 56.0 (C-17), 
the proton at δ 4.67 (H-18) was joined with the carbon at δ 49.8 (C-18), the proton at 
δ 3.84 (H-121) was joined with the carbon at δ 12.7 (C-121), the proton at δ 3.71 (H-
81) was joined with the carbon at δ 20.0 (C-81), and the proton at δ 3.32 (H-21) was 
joined with the carbon at δ 12.4 (C-21). The protons attached to the carbons in 
compound 25 were assigned by HMQC spectrum as shown in Figure A.13 and Table 
4.12. 
 
Table 4.12. Observed Correlations in HSQC Vicinal (C-H) Spectrum of Compound 
25 (in Pyridine d5). 
δ 1H-NMR (position) HSQC (attached carbon) 
                3.32 (H-21) 
                8.10 (H-31) 
                6.41 (H-32 E) 
                6.20 (H-32 Z) 
                9.66 (H-5) 
                       12.4 (C-21) 
                       129.3 (C-31) 
                       123.0 (C-32)  
                       123.0 (C-32) 
                       104.0 (C-5) 
 
 81
 
Table 4.12. (Continued). 
δ 1H-NMR (position) HSQC (attached carbon) 
                3.17 (H-71) 
                3.71 (H-81) 
                9.89 (H-10) 
                3.84 (H-121) 
                5.46 (H-17) 
                4.51 (H-18) 
                1.83 (H-181) 
                8.84 (H-20) 
                         11.4 (C-71) 
                         20.0 (C-81) 
                       108.9 (C-10) 
                         12.7 (C-121) 
                         56.0 (C-17) 
                         49.8 (C-18) 
                         24.4 (C-181) 
                         96.2 (C-20) 
 
      In the H-C long range coupling spectrum obtained by HMBC the proton at δ 9.89 
(H-10) showed cross peaks with the carbons at 140.8 (C-12), and 174.0 (C-8), the 
proton at δ 1.86 (H-181) showed a cross peak with the carbon at 177.7 (C-19), the 
proton at δ 8.84 (H-20) showed a cross peaks with the carbons at 144.8 (C-1) and 
133.0 (C-2), the proton at δ 6.41 (H-32 E) showed a cross peaks with the carbons at 
129.3 (C-31) and 138.0 (C-4), the proton at δ 5.46 (H-17) showed a cross peaks with 
the carbons at 178.3 (C-16), 32.4 (C-171), 23.3 (C-181), and 177.7 (C-19), and the 
proton at δ 4.67 (H-18) showed cross peaks with the carbons at 178.3 (C-16), 32.4 (C-
171), and 177.7 (C-19) (Figure A.14 , Figure 4.5, and Table 4.13). 
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Figure 4.5. The HMBC correlations of compound 25. 
 
Table 4.13. Observed Long Range C-H Correlation in the HMBC of Compound 25 
(in Pyridine d5).  
δ 1H-NMR (position) HMBC correlation carbon 
                 3.32 (H-21) 
                 8.10 (H-31) 
                 6.41 (H-32 E) 
                 6.20 (H-32 Z) 
                 9.66 (H-5) 
                 3.17 (H-71) 
144.8 (C-1), 133.0 (C-2), 137.9 (C-3) 
133.0 (C-2) 
129.3 (C-31), 138.0 (C-4) 
138.0 (C-4) 
138.0 (C-4) 
137.5 (C-7), 147.0 (C-8), 157.2 (C-6) 
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Table 4.13. (Continued). 
δ 1H-NMR (position) HMBC correlation carbon 
                 3.71 (H-81) 
                 1.69 (H-82) 
                 9.89 (H-10) 
                 3.84 (H-121) 
                 5.46 (H-17) 
 
                 4.51 (H-18) 
                 1.83 (H-181) 
                 8.84 (H-20) 
137.5 (C-7), 147.0 (C-8), 151.4 (C-9) 
147.0 (C-8), 20.0 (C-81) 
132.5 (C-11), 140.8 (C-12), 174.0 (C-8) 
95.1 (C-11), 140.8 (C-12) 
178.3 (C-16), 56.0 (C-17), 32.4 (C-171), 
33.6 (C-172), 23.3 (C-181), 175.6 (C-19) 
178.3 (C-16), 32.4 (C-171), 175.6 (C-19) 
175.6 (C-19), 51.1 (C-18), 56.0 (C-17) 
144.8 (C-1), 133.0 (C-2) 
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       4.2.3 Structure Elucidation of Compound 26 
                The characteristic dark green color and its UV spectrum (Figure A.15) 
suggested that compound 26 is a chlorophyll derivative compound (Watanabe et al., 
1993). 
                The IR spectrum of compound 26 is shown in Figure A.16 and the 
absorption peaks were assigned as shown in Table 4.14. 
 
Table 4.14. IR Absorption Bands Assignment of Compound 26. 
Wave Number (cm-1) Intensity Tentative Assignment 
3429 
2925, 2852 
1721, 1637 
1300, 1277, 1132, 1095 
s 
m 
m 
m 
             N-H Stretch 
             C-H Stretch 
             C=O Stretch 
             C-H Bend 
 
      Information from 1H-NMR and 13C-NMR spectra showed the necessary 
diagnostic peaks to be identified as a pheophorbide a. The 3H-71, 3H-21, and 3H-121 
resonances occurred as sharp singlets at δ 3.26, 3.38, and 3.69, respectively. H-5, H-
10, and H-20 were found as sharp singlets at δ 9.73, 9.90, and 8.86, respectively. A 
vinyl group was present at C-3 as indicated by the H-31 doublet of doublets at δ 8.22 
(J = 11.5, 17.8 Hz) and the H-32(E) and the H-32 (Z) doublet of doublets at δ 6.40 (J = 
17.8 Hz) and 6.21 (J = 11.6 Hz), respectively. An ethyl group was found to occur at 
C-8. The 2H-81 resonances appeared as quartet at δ 3.75 (J = 7.6 Hz) and 3H-82 
occurred as a triplet at δ 1.71 (J = 7.7 Hz). Similarly, as with pheophytin b, a five 
membered carbocyclic ring was present at position 13. A keto group was found at C-
 85
131, as indicated by the fully substituted carbon resonance at δ 190.3. The C-132 
resonances occurred at δ 65.9 as with pheophorbide a and a methyl ester was also 
present at C-133. This was indicated by C-133 occurring as a fully substituted carbon 
resonance at δ 170.8 and the C-134 methyl carbon resonance being present at δ 53.2. 
The H-134 resonance was found as a sharp singlet at δ 3.93.  
      Compound 26 exhibited the 1H-NMR and 13C-NMR chemical shifts identical to 
pheophobide a (Ohshima et al., 1994). A comparison of the 1H-NMR and 13C-NMR 
chemical shifts of compound 26, pheophobide a and pheophorbide a methyl ester 
(Sakata et al., 1990) are shown in Tables 4.15 and 4.16. These data indicated that 
compound 26 is pheophobide a (Figure 4.6).  
 
 
 
Figure 4.6. Structure of compound 26. 
 
 86
Table 4.15. The 1H-NMR Chemical Shifts of Compound 26& and Pheophobide a* and 
Pheophobide a Methyl Ester*.  
Chemical Shifts (ppm), Coupling Constant (Hz)  
Proton 
Position 
Compound 26  Pheophobide a  Pheophorbide a Methyl 
Ester  
  21
  31
 
  32 (E) 
 
  32 (Z) 
 
  5 
  71
  81
  82
10 
121
132
134
17 
 
3.38 (s) 
8.22 (dd, J = 17.8, 
11.5) 
6.40 (dd, J = 17.8, 
1.1) 
6.21 (dd, J = 11.6, 
1.1) 
9.73 (s) 
3.26 (s) 
3.75 (q, J = 7.6) 
1.71 (t, J = 7.7) 
9.90 (s) 
3.69 (s) 
6.90 (s) 
3.93 (s) 
4.59 (m) 
 
3.34 (s) 
7.89 (dd, J = 17.8, 
11.5) 
6.11 (dd, J = 11.5, 1.5) 
 
6.21 (dd, J = 17.8, 1.5) 
 
9.25 (s) 
3.13 (s) 
3.57 (q, J = 7.3) 
1.63 (t, J = 7.5) 
9.40 
3.62 (s) 
6.23 (s) 
3.85 (s) 
4.18 (m) 
 
3.41 (s) 
8.00 (dd, J = 18.0, 
11.4) 
6.30 (dd, J = 18.0, 1.5) 
 
6.19 (dd, J = 11.5, 1.5) 
 
9.40 (s) 
3.24 (s) 
3.70 (q, J = 7.5) 
1.70 (t, J = 7.5) 
6.25 (s) 
3.69 (s) 
1.70 (t) 
3.88 (s) 
4.21, (dddt, J = 9.0, 
3.2, 1.6, 0.2) 
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Table 4.15. (Continued). 
Chemical Shifts (ppm), Coupling Constant (Hz)  
Proton 
Position 
Compound 26 Pheophobide a Pheophobide a Methyl 
Ester  
171
 
171
 
172
 
172
 
18 
181
20 
NH 
3.10 (m) 
 
2.70 (m) 
 
2.99 (m) 
 
2.79 (m) 
 
4.66 (q)  
1.86 (d, J = 7.2) 
8.86 (s) 
0.89 (br. s), -1.30 
(br. s) 
 
             2.28 (m) 
 
 
 
             2.59 (m)        
 
 
4.43 (dq, J =7.3, 2.0) 
1.80 (d, J =7.3) 
8.52 (s) 
 
2.64 (dddd, J = 14.0, 
9.9, 6.7, 3.2) 
2.32 (dddd, J = 14.0, 
9.3, 9.0, 5.2) 
2.52 (dddd, J = 15.7, 
9.3, 6.7, 0.2) 
2.23 (dddd, J = 14.0, 
9.3, 9.0, 5.2) 
4.45 (dq, J = 7.3, 1.6) 
1.81 (d, J = 7.3) 
8.56 (s) 
0.56 (br, s), -1.61(br, s) 
& 500 MHz 1H, pyridine d5
* 400 MHz 1H, CDCl3
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Table 4.16. 13C-NMR Chemical Shifts of Compound 26& and of Pheophobide a 
Methyl Ester*.  
Carbon Position compound 26 (ppm) Pheophobide a Methyl 
Ester (ppm) 
                  1 
                  2 
                  21
                  3 
                  31
                  32
                  4 
                  5 
                  6 
                  7 
                  71
                  8 
                  81
                  82
                  9 
                10 
                11 
                12 
                121
                  142.7 
                  133.0 
                    12.5 
                  136.8 
                  129.9 
                  123.0 
                  137.3 
                    90.3 
                  156.4 
                  137.3 
                    11.6 
                  146.2 
                    20.0 
                    18.0 
                  152.0 
                  105.5 
                  138.8 
                  129.7 
                    12.3 
                  142.0 
                  131.8 
                    12.0 
                  136.5 
                  129.0 
                  122.6 
                  136.2 
                    97.5 
                  155.6 
                  136.2 
                    11.2 
                  145.1 
                    19.3 
                    17.3 
                  150.9 
                  104.3 
                  137.9 
                  129.0 
                    12.0 
 
 89
Table 4.16. (Continued). 
Carbon Position compound 26 (ppm) Pheophobide a Methyl 
Ester (ppm) 
                13 
                131
                132
                133
                134
                14 
                15 
                16 
                17 
                171
                172
                173
                18 
                181
                19 
                20 
                  130.1 
                  190.3 
                    65.9 
                  170.8 
                    53.2 
                  150.5 
                  106.9 
                 163.0 
                   52.5 
                   31.2 
                   32.9 
                 177.8 
                   50.8 
                   23.6 
                 173.8 
                   94.6 
                  129.0 
                  189.6 
                    64.8 
                    69.6 
                    51.6 
                  149.7 
                  105.3 
                  161.2 
                    51.2 
                    31.1 
                    29.9 
                  173.3 
                    50.2 
                    23.1 
                  172.2 
                    93.1 
& 125 MHz 13C, pyridine d5 
* 100 MHz 13C, CDCl3
 
      Further studies of the structure of compound 26 were done by analysis of COSY, 
HSQC, and HMBC correlations (see also Figures A.19-21 and Tables 4.17-4.19). 
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      The COSY spectrum (Figure A.19) gave indication that one proton doublet of 
doublets at δ 8.22 (H-31) coupled to one proton doublet of doublets at δ 6.40 (H-32 E), 
and one proton doublet of doublets at δ 6.21 (H-32 Z). The signal at δ 3.75 (H-81) 
correlated only with the signal at δ 1.71 (H-82). The signal of one proton at δ 4.66 (H-
18) showed a cross peak with the signal at δ 4.59 (H-17). Study of the COSY (H-H) 
spectrum led to the complete assignment of 1H and 13C shift signals as shown in Table 
4.17.  
 
Table 4.17. Observed Correlation in the COSY (H-H) Spectrum of Compound 26 (in 
Pyridine d5). 
δ 1H-NMR (position) COSY (coupled hydrogen) 
                        8.82 (H-31) 
                        3.75 (H-81) 
                         4.59 (H-17) 
                        4.66 (H-18) 
             6.40 (H-32 E), 6.21 (H-32 Z) 
                         1.71 (H-82) 
             3.10, 2.70 (H-171) 
             4.59 (H-17), 1.86 (H-181) 
 
      One Bond Correlation (HSQC) data revealed that the proton at δ 9.90 (H-10) was 
attached to the carbon at δ 105.5 (C-10), the proton at δ 9.73 (H-5) was attached to the 
carbon at δ 90.3 (C-5), the proton at δ 8.86 (H-20) was attached to the carbon at δ 
94.6 (C-20), the proton at δ 8.82 (H-31) was attached to the carbon at δ 129.9 (C-31), 
the protons at δ 6.40 (H-32 E) and 6.21 (H-32 Z) were attached to the carbon at δ 
123.0 (C-32), the proton at δ 4.59 (H-17) was joined with the carbon at δ 52.5 (C-17), 
the proton at δ 4.66 (H-18) was joined with the carbon at δ 50.8 (C-18), the proton at 
δ 3.69 (H-121) was joined with the carbon at δ 12.3 (C-121), the proton at δ 3.75 (H-
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81) was joined with the carbon at δ 20.0 (C-81), and the proton at δ 3.38 (H-21) was 
joined with the carbon at δ 12.5 (C-21).The protons attached to the carbons in 
compound 26 were assigned by HSQC spectrum as shown in Figure A.20 and Table 
4.18. 
 
Table 4.18. Observed Correlation in HSQC Vicinal (C-H) Spectrum of Compound 26 
(in Pyridine d5). 
δ 1H-NMR (position) HSQC (attached carbon) 
                3.38 (H-21) 
                9.90 (H-10) 
                8.22 (H-31) 
                6.40 (H-32 E) 
                6.21 (H-32 Z) 
                9.73 (H-5) 
                3.26 (H-71) 
                3.75 (H-81) 
                3.69 (H-121) 
                4.59 (H-17) 
                4.66 (H-18) 
                1.86 (H-181) 
                8.86 (H-20) 
                12.46 (C-21) 
              105.5 (C-10) 
              129.9 (C-31) 
              123.0 (C-32) 
              123.0 (C-32) 
                90.3 (C-5) 
                11.6 (C-71) 
                20.0 (C-81) 
                12.3 (C-121) 
                52.5 (C-17) 
                50.8 (C-18) 
                23.6 (C-181) 
                94.6 (C-20) 
 
      In the H-C long range coupling spectrum obtained by HMBC, the proton at δ 6.90 
(H-132) showed cross peaks with the carbons at 106.9 (C-15) and 150.5 (C-14), the 
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proton at δ 1.86 (H-181) showed a cross peak with the carbon at 173.8 (C-19), the 
proton at δ 9.90 (H-10) showed a cross peaks with the carbons at δ 146.2 (C-8), 50.8 
(C-18), and 52.5 (C-17), the proton at δ 9.73 (H-5) showed a cross peak with the 
carbon at 136.8 (C-3), the proton at δ 8.86 (H-20) showed a cross peaks with the 
carbons at 133.0 (C-2), 142.7 (C-1), and 50.8 (C-18), and the proton at δ 8.22 (H-31) 
showed cross peaks with the carbons at 133.0 (C-2), 137.3 (C-7), and 137.3 (C-4) (see 
also Figure A.21, Figure 4.6, and Table 4.19). 
 
 
 
Figure 4.7. The HMBC correlations of compound 26. 
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Table 4.19. Observed Long range C-H Correlation in the HMBC of Compound 26 (in 
Pyridine d5).  
δ 1H-NMR (Position) HMBC (Correlation Carbon) 
                     3.38 (H-21) 
                     8.22 (H-31) 
 
                     6.40 (H-32 E) 
                     6.21 (H-32 Z) 
                     9.73 (H-5) 
                     3.26 (H-71) 
 
                     3.75 (H-81) 
 
                     1.71 (H-82) 
                     9.90 (H-10) 
                     3.69 (H-121) 
                     6.90 (H-132) 
 
                     3.93 (H-134) 
                     4.59 (H-17) 
 
                     1.86 (H-181) 
                     4.66 (H-18) 
                     8.86 (H-20) 
142.4 (C-1), 133.0 (C-2), 136.8 (C-3) 
133.0 (C-2), 123.0 (C-32), 137.3 (C-7), 
137.27 (C-4) 
129.7 (C-31), 137.3 (C-4), 137.3 (C-7) 
137.3 (C-7), 137.3 (C-4) 
136.76 (C-3), 137.27 (C-4) 
137.3 (C-4), 156.4 (C-6), 137.3 (C-7), 146.2 
(C-8) 
146.2 (C-8), 151.7 (C-9), 137.3 (C-7), 
137.27 (C-4) 
146.2 (C-8), 20.0 (C-81) 
146.2 (C-8), 50.8 (C-18), 52.5 (C-17) 
138.8(C-11), 129.7(C-12), 130.0(C-13) 
190.3 (C-131), 170.8 (C-133), 106.9 (C-15), 
150.5 (C-14) 
170.8 (C-133) 
173.8 (C-19), 23.6 (C-181), 31.2 (C-71), 
32.9 (C-172) 
173.8 (C-19) 
31.2 (C-171), 23.6 (C-181), 173.8 (C-19) 
133.0 (C-2), 142.7 (C-1), 50.8 (C-18) 
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CHAPTER V 
CONCLUSION 
 
      The dried powdered leaves of C. nutans were extracted consecutively with hexane 
and chloroform. The chloroform crude extract was separated by column 
chromatography and further purified by preparative thin layer chromatography giving 
three pure compounds. Structures of isolated compounds were elucidated on the basis 
of NMR spectral analysis, including DEPT, COSY, HMQC, HMBC, and NOESY 
with literature values. Three isolated compounds were identified as chlorophyll a and 
chlorophyll b related compounds, 132–hydroxyl-(132–S)-pheophytin b (24), purpurin 
18 phytyl ester (25) and pheophobide a (26), which have not been previously reported 
in this species.  
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APPENDIX 
 
 
Figure A.3. 500 MHz 1H-NMR spectrum of compound 24 in pyridine d5. 
 
 
 
Figure A.4. 125 MHz 13C- NMR spectrum of compound 24 in pyridine d5. 
  
Figure A.6. Gradient HSQC spectrum of compound 24. 
 Figure A.7. Gradient HMBC spectrum of compound 24. 
 
 Figure A.11. 500 MHz 1H-NMR spectrum of compound 25 in pyridine d5. 
 Figure A.12. 125 MHz 13C- NMR spectrum of compound 25 in pyridine d5. 
 Figure A.14. Gradient HMBC spectrum of compound 25. 
 
 
 
Figure A.19. Gradient COSY spectrum of compound 26. 
 
 
Figure A.18. 125 MHz 13C- NMR spectrum of compound 26 in pyridine d5. 
 
 
Figure A.19. Gradient COSY spectrum of compound 26. 
 
 
Figure A.20. Gradient HSQC spectrum of compound 26. 
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